antaranusa.com | berita nusantara internasional

Green SM Forges Partnerships With 10 Strategic Partners to Expand Its Green Mobility Ecosystem in Laos

Tue, 10 Nov 2026 20:40:00 +0700

Photo: Ms. Le Thi Ngoc Linh - Deputy CEO of Operations at Green SM (seventh from left) and Mr. Nguyen Minh Tam - Ambassador Extraordinary and Plenipotentiary of Vietnam to Laos (seventh from right), alongside representatives of the partner organizations at the MOU signing ceremony.

Source: Green SM

VIENTIANE, LAOS- Media OutReach Newswire - 10 November 2026 - Green SM has entered into Memoranda of Understanding (MOUs) with 10 strategic partners in Laos, spanning the banking and finance, telecommunications, payment, media, and hospitality sectors. The partnerships aim to strengthen platform connectivity, integrate services, and introduce value-added offerings for customers, further expanding Green SM's green mobility ecosystem and delivering a more seamless mobility experience in the Lao market.

Under the theme "Green Alliance Frontier" - "Where Pioneers of the Green Economy Come Together," the signing ceremony was held to mark the third anniversary of Green SM's official launch of electric taxi services in the "Land of a Million Elephants," with the attendance of Mr. Nguyen Minh Tam, Ambassador Extraordinary and Plenipotentiary of Vietnam to Laos.

The 10 partners signing MOUs with Green SM include VietinBank Laos, Joint Development Bank Public, MB Bank Laos, and Sacombank Laos in banking and finance; Unitel, ETL, and Lao Telecoms (M-Money) in telecommunications and payments; Good Media (Bawanli) in transportation and travel; and Muong Thanh Luxury Vientiane Hotel and Latsavong Wanda Vista Hotel in hospitality.

Under the agreements, Green SM and its partners will build on their respective strengths in technology, services, and customer networks to explore opportunities to integrate electric mobility solutions into their existing service ecosystems. The parties will also work together to develop exclusive promotions and customer engagement programs, making Green SM services more accessible and convenient through platforms that customers already use.

In the tourism and hospitality sectors, the partnerships will explore ways to connect Green SM's mobility services with hotel networks and other service providers, offering convenient transportation options for hotel guests, international visitors, and corporate customers. Collaboration with media partners will also create opportunities for joint branding and promotional campaigns, helping raise awareness of the benefits of electric mobility and bring greener transportation choices closer to the community.

A highlight of the event was Frontier Mark, an artwork that brings together the distinctive marks of all participating partners to form a shared symbol, reflecting their collective spirit of collaboration and common vision for building a green ecosystem in Laos.

Ms. Le Thi Ngoc Linh, Deputy CEO of Mobility Services Operation at Green SM, said: "The transition to a greener future requires the collaboration and collective efforts of businesses and organizations across different sectors. Through Green Alliance Frontier, we aim to create a platform for Green SM and its partners to connect, share a common vision, leverage their respective strengths, and explore meaningful opportunities for collaboration. By bringing together platforms, services, and customer networks, we hope to make green mobility solutions more accessible to local communities while contributing to sustainable value creation for the people and market of Laos."

After three years of operations in Laos, Green SM has completed nearly 4.6 million rides in the country. Its partnerships with 10 strategic partners further expand Green SM's local network, paving the way for the integration of green mobility services with essential everyday conveniences and better addressing the transportation needs of residents and visitors.

Through cross-sector collaboration, Green SM and its partners aim to make electric mobility solutions more accessible, provide additional convenience for customers, and contribute to the development of sustainable transportation in Laos.

The issuer is solely responsible for the content of this announcement.

Hashtags: #GreenSM

onsemi's EliteSiC M4 Pushes Power Density Higher as Energy Demands Grow

Tue, 10 Nov 2026 20:32:00 +0700

Fourth-generation silicon carbide platform based on a trench architecture reduces losses while enabling more compact power systems across AI, EV and energy applications.

Summary

onsemi introduced EliteSiC M4, its fourth-generation silicon carbide platform built on a trench architecture, delivering up to 30% higher power density and 35% lower losses compared with the previous generation. By advancing conduction and switching performance, EliteSiC M4 enables more efficient, power-dense systems for AI data centers, electric vehicles and energy infrastructure.

News Highlights:

EliteSiC M4 delivers higher power density and lower losses enabling customers to increase performance and efficiency while optimizing system size and managing cooling requirements

Extends onsemi's proven SiC leadership, building on more than 16 billion miles of real-world operation

EliteSiC M4 750 V automotive traction bare die available now, with additional voltage options up to 1200 V expected in 2027

SCOTTSDALE, Ariz., Nov. 10, 2026 (GLOBE NEWSWIRE) -- onsemi (Nasdaq: ON) today introduced EliteSiC M4, its fourth-generation silicon carbide (SiC) platform built on a trench architecture and designed to set a new performance benchmark for next-generation power systems.

With industry-leading conduction and switching performance, EliteSiC M4 gives customers greater design freedom to increase power density and efficiency up to 30% and lower losses by 35%, enabling more efficient, power-dense systems across EVs, AI data center and industrial applications.

"Power requirements are rising faster than the physical infrastructure around them. The next generation of power systems will require the ability to deliver more power, more efficiently and in less space," said Achyut Shah, Group President of the Power Solutions Group at onsemi. "With more than 16 billion miles of proven silicon carbide operation in vehicles around the world, EliteSiC M4 is combining that foundation of reliability with the performance customers need to rethink the balance among power, efficiency, size and cost."

Delivering More Power Within Real-World Constraints

The growth of AI, electrification and energy infrastructure is creating a common challenge for power-system designers - delivering significantly more power without proportional increases in size, energy losses, and cooling requirements. EliteSiC M4 addresses that challenge by expanding the power and efficiency available within existing system constraints, giving customers greater flexibility to scale AI infrastructure, electric vehicles and industrial systems.

Across its key markets, EliteSiC M4 translates these technology advances into distinct system-level benefits:

AI Data Centers: Scaling compute without scaling power infrastructure at the same rate. Higher-density power conversion helps data centers get more compute from every megawatt, maximizing capacity while reducing the supporting infrastructure required per unit of compute

Electric Vehicles: Getting more performance from the electric drivetrain. More compact, efficient traction inverters can help automakers improve vehicle range

Energy Infrastructure: Making more of every unit of energy. More efficient, higher-density power conversion helps solar, energy storage and other high-voltage systems reduce conversion losses

"As vehicle power levels increase, traction-inverter design becomes a tighter balancing act between efficiency, thermal performance, power density and reliability," said Harald Hartel, Vice President, BU eMotor Controls at Schaeffler AG. "Higher efficiency and power density can give us greater flexibility to optimize the traction inverter for range, thermal performance and packaging, which are increasingly important as electrified powertrains become more demanding."

A New Architecture for Higher Power Density and Efficiency

EliteSiC M4 improves conduction and switching performance without compromising reliability. Key improvements over the previous generation include:

Improvement in specific on-resistance (RSP): Reduces specific RSP between 20% - 50%, while enabling faster switching

Lower switching losses: Improves switching figures of merit by 67% in hard-switching and 50% in soft-switching, supporting compact power-supply designs

Broad packaging flexibility: Designed to support existing packages, including top-side-cooled surface-mount packages and high-power modules

Ruggedness for demanding applications: The platform is also designed for demanding operating environments, with qualification supporting temperatures of 185?C and above, enabling use in high-voltage automotive and space applications

Availability

The EliteSiC M4 750 V bare die for automotive traction inverters is available now. Additional product offerings for a range of voltages up to 1200 V are expected to be available beginning in 2027.

More Information:

Learn More about EliteSiC Solutions

Media Assets: onsemi M4 Platform

White Paper: Advancing Power Density with EliteSiC M4

About onsemi

onsemi (Nasdaq: ON) delivers intelligent power and sensing technologies that enable electrification, energy efficiency, safety, and automation across automotive, industrial, and AI data center end-markets. With a highly differentiated and innovative product portfolio, onsemi helps customers solve complex challenges to achieve higher efficiency, improved performance, and lower system cost, while supporting a safer, cleaner, and more energy-efficient world. The company is part of the S&P 500? index. Learn more at www.onsemi.com.

onsemi and the onsemi logo are trademarks of Semiconductor Components Industries, LLC. All other brand and product names appearing in this document are registered trademarks or trademarks of their respective holders. Although the Company references its website in this news release, information on the website is not to be incorporated herein.

Zoho brings trusted business intelligence to AI agents in Zoho Analytics platform evolution, connecting data, business context, insights and action

Tue, 10 Nov 2026 20:25:00 +0700

Source: Zoho Corporation

*Trusted intelligence: Zoho Analytics serves as the intelligence layer for businesses, grounding AI agents in trusted data and business context and extending intelligence across the Zoho app ecosystem

*Built on business context: Native semantic and ontology layers help AI agents understand business data, relationships, metrics and priorities

*From Data to Insights and Actions: AI super agent orchestrates specialized agents for data analysis, preparation, modeling, visualization and coding through a single interface

*Strict governance and security controls provides oversight across the whole chain, from raw data to agent answers, from one place

SINGAPORE - Media OutReach Newswire - 10 November 2026 - Zoho Corporation, a global technology company, today announced a major evolution of Zoho Analytics into an Agentic Analytics platform, extending its established analytics and reporting capabilities with a trusted intelligence layer for business insights and AI-driven action.

By bringing together data, business context, analytics, and AI agents, the platform enables businesses to move from analyzing data to understanding what it means and to act on those insights. Native semantic and ontology layers provide the business context that powers a multi-agent version of Ask Zia and enables intelligence to extend across business analytics, agents, apps, and workflows.

"We are at the beginning of the next leap forward in data analytics, where a strong data foundation is the starting point for all agentic activity in business operations," says Gibu Mathew, Managing Director, Zoho APAC. "Agents, however, cannot function only with data, but require a robust intelligence layer. Today's updates to Zoho Analytics provide that and more: one open and extensible trusted intelligence layer that gives every AI tool in your business the context, metrics, and governance to deliver answers users can rely on."

Zoho Analytics finely tunes its data intelligence by modeling its structure on an organization's data. The semantic layer serves as a business glossary for AI, defining key terms, metrics and their meaning, helping AI interpret data in the context of an organization's operations.

The ontology layer models business entities, their relationships, and how they connect across the organization, helping AI generate insights and recommendations that are relevant to the real business needs. With strict governance and clear oversight into each step of its process, Zoho Analytics helps businesses manage data access, cost, reduce errors and maintain control over how information is used by agents, in this nascent AI regulatory landscape.

The intelligence layer delivers trusted, repeatable and pervasive intelligence, enabling agentic AI to ask, understand, decide, and act based on highly informed data, tailored to each unique business. Ask Zia, a conversational super-agent for Business Intelligence is built with a multi-agent architecture across data analysis, data modeling, visualization, data preparation, coding and SQL generation. A central agent plans and orchestrates the specialized sub-agents, all working off the same semantic layer, ontology and conversation context.

This enables users to move naturally between tasks - for example, starting with an analysis and then creating a data pipeline to prepare data for further use - without losing the context of the conversation. For specific functions, users can build custom agents that are grounded with the same data, semantic model and knowledge base as Ask Zia. With support for the Model Context Protocol (MCP), these agents can connect with external tools and systems, in addition to built-in tools from Zoho Analytics.

With this evolution, Zoho Analytics brings data analysis, business context, AI-powered insights, and agent-driven workflows together in one platform, helping businesses move from data to decisions and action with greater confidence.

Business Context for Trusted Intelligence

Zoho Analytics calibrates itself to the way a business operates using three distinct tools:

The Ontology Layer

By leveraging provided tools to model their canonical business units and describing how those entities relate to one another, organizations can provide AI with a structured understanding of the business-helping AI generate insights and recommendations that are relevant and reliable, addressing real business needs and ensuring results are tailored precisely to achievable outcomes and tied directly to process.

The Semantic Layer

Users can produce a business glossary for AI that standardizes descriptions, synonyms, instructions, and metrics. This ensures AI is fluent in the language of an organization and can properly interpret its findings. Zoho Analytics includes support for multiple semantic models for different contexts.

More Connectors Than Ever

Zoho Analytics adds more than 30 new data connectors to the 500-plus already available. New connectors expand Zoho integrations by adding support for Zoho ERP, Zoho Spend, Zoho FSM, Zoho Shifts and Zoho Voice; other connectors expand interoperability to include SAP, PayPal, Adobe Commerce, Twilio, Notion, Intercom, Supabase, Amazon DocumentDB, and AlloyDB, bringing relevant data into Zoho Analytics for analysis and insights.

Unlike competitors, the semantic and ontology layers are native to Zoho Analytics, and arrive in the box, not requiring a separate data platform or cloud data warehouse. Users can create multiple semantic models for different contexts, so finance and operations departments each get the definitions that fit their work. Apache Ossie compatibility means that a company's definitions are portable, and not locked inside of Zoho. Businesses can build and edit semantic models without code.

Flexible Super Agents, Finely Attuned

*Ask Zia

Zoho's conversational agent for business intelligence, natively integrated into Zoho products, has adopted a multi-agent architecture with six pre-built specialized sub-agents for data analysis, visualization, data preparation, modeling, coding, and SQL generation. Ask Zia works within an organization's ontology and semantic layer, retains conversation history and agent memory, and allows organizations to choose Zia's own large language model or bring their own frontier model.

*Custom agents

Teams can build their own data agents that remain grounded in an organization's data, semantic model, and knowledge base. These agents connect to Model Context Protocol (MCP) servers, web search, and other tools inside or outside Zoho Analytics, and can be distributed with governance and observability controls.

*Agentic actions

Agents can trigger actions and workflows directly. Powerful workflows can be designed with a workflow builder in Zoho Analytics.

Portable Intelligence for Agents, Apps, and Workflows

Zoho Analytics extends its intelligence beyond its own interface, enabling developers and organizations to use its analytics capabilities and business context across external agents, applications, and workflows.

Headless BI

Developers and agents can build agentic solutions over the Zoho Analytics MCP server, available in remote and local options, with tools for data analysis, data preparation, and visualization. A new command-line interface (CLI) is included, and users can work with Zoho Analytics from inside Claude through a Claude plug-in.

Embedded AI

Organizations can embed agents in their own apps, portals, and products with white labeling. Permissions and governance remain intact wherever the agents run.

Built-In Governance and Oversight

Zoho Analytics gives administrators visibility into, and control over, how agents operate across the organization:

Data Catalog

A unified catalog of data, metrics, analytics assets, and models offers lineage and impact analysis, broad search options, and management of data and access policies.

AI Observability

Administrators can see which agents ran, who used them, what they accessed, and how they answered queries. AI usage and cost tracking across teams, along with administrative controls for Ask Zia, helps organizations monitor and manage AI adoption.

Sandbox and Deployment Management

Teams can develop and test analytics artifacts and agents in a sandbox, publish to production when ready, and roll back to previous versions if necessary.

Additional Capabilities

Zoho Analytics includes more than 50 new capabilities beyond its agentic features. These include more than 10 new visualizations, custom visuals, and pixel-perfect reports; predictive tools such as scenario analysis, a correlation matrix, and a VARX forecasting model; a data science studio with Jupyter notebooks, PMML import, and expanded analysis types; and Ask Zia in mobile with an upgraded interface.

Zoho Analytics is used by 100,000 businesses worldwide daily and is available on Zoho Cloud, on-premises; on public cloud infrastructure including AWS, Azure, and Google Cloud; and in hybrid deployments.

For a complete description of what's new to Zoho Analytics, visit https://www.zoho.com/analytics/whats-new.html.

What's Next

Today's updates lay the foundation for the next iteration of Zoho Analytics, with more to come. Future enhancements include:

From designed to dynamic business context: the "designed context" from the semantic and ontological layers will expand into "dynamic business context," continually observing how business data changes over time, providing even more trusted outcomes.

Decision intelligence: As Zoho Analytics observes actions triggered through agents, the outcomes observed will provide deep Decision Intelligence, further serving as another context for Agentic AI.

Greater openness and interoperability: Zoho Analytics will continue to invest in open standards, following the Apache Ossie specification as it matures, integrating with Semantic Models defined in other third party platforms, and bringing more of the Analytics platform to outside agents via MCP.

Becoming a full Unified Data Platform: Zoho Analytics will serve as the foundation for the upcoming Data platform that brings together a data lakehouse (supporting both structured and unstructured data), data integration, data preparation, business context, analytics, data science, packaged business models (Cx360, CMDP), and agent building. Deeper integration across the Zoho ecosystem will help establish the upcoming Data Platform as a common data and intelligence infrastructure for agentic AI.

Pricing and Availability

Despite extensive updates, pricing for Zoho Analytics remains unchanged. Now included in each plan are Zoho LLM credits. A Basic plan begins at US$24 per month, billed annually, which covers 2 users, 0.5 million rows, and 10K Zoho LLM credits.

For full pricing, visit www.zoho.com/analytics/pricing.html.

Updates to the cloud version of Zoho Analytics are available now, with preview versions of pixel-perfect reporting, ontology and the semantic model to be rolled out globally in the next four to eight weeks.

Updates to the on-premise version of Zoho Analytics will be available in Q1 2027.

Zoho Corporation

With 60+ apps in nearly every major business category, Zoho Corporation is one of the world's most prolific technology companies. Zoho is privately held and profitable with more than 19,000 employees globally, with international headquarters in Chennai, India. Zoho APAC HQ is located in Singapore. Zoho respects user privacy and does not have an ad-revenue model in any part of its business, including its free products. The company owns and operates its data centers, ensuring complete oversight of customer data, privacy, and security. More than 150 million users worldwide rely on Zoho every day to run their businesses. For more information, please visit: www.zoho.com

The issuer is solely responsible for the content of this announcement.

Hashtags: #Zoho

https://www.zoho.com

https://www.linkedin.com/company/zohoapac

LUYUAN and LYVA Make European Debut at EICMA 2026, Outlining Next Steps for Global Growth

Tue, 10 Nov 2026 20:21:00 +0700

MILAN, Nov. 10, 2026 (GLOBE NEWSWIRE) -- LYVA, LUYUAN Group's global premium smart-mobility brand, has concluded its European debut at EICMA 2026 with five concept models, industry media visits and the launch of its Global Co-Creation programme.

Cargo R07 and the Z05 multi-folding electric kickscooter attracted strong interest from visitors. European users were particularly drawn to their distinctive mechanical structures, practical functions and design aesthetics. Cargo R07 received especially positive feedback from families, with many visitors taking an interest in its potential for carrying children and everyday goods.

Unlike conventional front-loading cargo designs, Cargo R07 is an electric-assist tricycle with a rear cargo platform. Its tilting architecture allows the vehicle to lean through corners while keeping the cargo platform stable, supporting a more comfortable and reassuring ride for both passengers and goods. The design resonated with families seeking a practical mobility solution for daily travel, school runs and short-distance transportation.

Z05 features a multi-folding structure that creates an ultra-compact package for storage in car boots and carrying on public transport. Visitors responded positively to its convenience and portability, particularly for multimodal travel and last-mile commuting.

The wider portfolio included T05, an e-trekking bike concept with a one-piece die-cast magnesium-alloy frame, and the GX03 and GX05 E-dirtbike concepts. GX05 demonstrated approximately five-minute disassembly, showing how its modular structure can simplify storage for users without garages and make it easier to transport the vehicle in an SUV for outdoor riding.

Alongside the vehicles, LYVA presented an integrated technology platform covering power, energy and AI-assisted riding systems. Liquid-cooled motors, electronic shifting and adaptive torque control deliver smoother and more responsive riding.

Journalists from Moto.it,1000PS and vaielettrico.it visited the booth for product presentations and interviews. The LYVA Global Co-Creation programme welcomed its first three Co-Creators. With100 spots available, riders can join via LYVA's website and social media to contribute through test rides, reviews and feedback.

Following EICMA, LYVA will continue to prioritise European engineering and market development. EPP Engineering supports local engineering development and validation, while LYVA plans to combine online channels with specialist European dealers.

About LYVA

LYVA is a premium brand established by LUYUAN Group (HK.02451), focused on smart mobility and intelligent light-mobility solutions. LYVA brings together technology and design to address diverse commuting, recreational and everyday mobility needs.

Tektronix puts more discovery within reach with new 1 Series DPO

Tue, 10 Nov 2026 20:18:00 +0700

New oscilloscope brings advanced capabilities, an intuitive experience and a compact design at an accessible price to university students, educators and engineers

BEAVERTON, Ore., Nov. 10, 2026 (GLOBE NEWSWIRE) --

Engineering starts with a question. Today, Tektronix introduces the 1 Series, a compact digital phosphor oscilloscope (DPO) designed to give more people the tools to pursue the answer, from university students making their first measurements to experienced engineers who need a versatile instrument across a range of engineering environments.

Starting at under $500, the 1 Series combines advanced acquisition and analysis capabilities with an intuitive user interface. With up to four analog channels, 12-bit vertical resolution, serial protocol analysis and integrated signal generation on select models, the 1 Series gives students room to move beyond basic measurements while giving experienced engineers the performance and tools for everyday design, debug and test.

Designed with a compact footprint, the 1 Series brings capable measurement to more places, whether on the bench, across the lab, or in a remote work setup. That combination of capability, compact design and accessible price gives the instrument a role across education, embedded design and debug, electronics test and repair, automated test and general-purpose engineering.

"Engineering is a constant learning curve. The earlier the right tools get into an engineer's hands, the sooner they can connect theory with what they actually see and measure, and the better prepared they are to solve real problems," said Daryl Ellis, Vice President and General Manager of Signal Acquisition and Analysis Portfolio at Tektronix. "We designed the 1 Series to give students and educators access to serious measurement capability early, while giving engineers at every level an instrument that's capable, approachable and flexible enough to keep close at hand."

Built for the next question

An oscilloscope makes the invisible visible. For a university student, seeing an electrical signal and measuring how it responds can connect a concept learned in a textbook or simulation with the behavior of real-world signals. For an experienced engineer, the same capabilities can help reveal why a design isn't behaving as expected and where to look next. The 1 Series brings those experiences together in an approachable instrument with capabilities that extend well beyond basic waveform viewing.

Key capabilities include:

More signals, more detail: Up to four analog channels, 12-bit vertical resolution, up to 200 MHz bandwidth, 1.25 GS/s sample rate and 10 Mpoints of record length per channel provide the acquisition performance to investigate more complex designs.

Deeper insight into embedded systems: Serial protocol decode for I2C, SPI and UART, along with FFT, limit testing and automated measurements, helps engineers move from seeing a signal to understanding its behavior.

More capability in one instrument: Select models add an integrated 25 MHz arbitrary function generator (AFG) and Bode plot analysis, allowing engineers to generate signals, measure circuit response and analyze behavior without adding another instrument to the bench.

An intuitive experience: A 7-inch multi-touchscreen brings the TekScope user interface found across the Tektronix oscilloscope portfolio to the 1 Series. The common UI shortens the ramp from first use to useful measurement for engineers learning the instrument, while giving experienced engineers a familiar way to work.

For educators, the 1 Series brings hands-on learning into the instrument itself. Instructors can disable automated settings and measurements to keep students focused on fundamental signal concepts, while e*Scope extends access beyond the lab and lets instructors view student work remotely. An extensive help system, with direct access to video demonstrations and measurement how-tos, provides support as students learn to make and interpret measurements, then apply those skills to more sophisticated project work.

The familiar TekScope interface also creates continuity across the Tektronix oscilloscope portfolio. Skills and workflows learned on the 1 Series transfer to higher-performance Tektronix oscilloscopes, reducing the need to relearn how to interact with the instrument as measurement requirements advance. For experienced engineers, that continuity works in the other direction as well, bringing familiar workflows to a smaller, more accessible instrument.

Designed for wherever engineering happens

At just 4.8 pounds, the 1 Series is easy to move between work locations, while its 4-inch depth helps it fit where space is limited. VESA mounting and an optional rackmount kit provide additional flexibility in how and where the instrument is deployed. Combined with its measurement capacity and accessible price, that compact design also makes the 1 Series a practical additional scope for everyday work or added measurement capacity without tying up a higher-performance instrument.

The 1 Series also fits into remote and automated workflows. Ethernet and USB connectivity support remote and programmatic control, while Python-based automation allows engineers to integrate the scope into larger test systems and software workflows.

As Tektronix works to put powerful measurement tools in the hands of more engineers, the company is also exploring how AI can make the expertise behind those tools easier to access and apply.

Extending discovery with AI

Beginning today, customers can be among the first to access the Tek Intelligence? connector, a new way to connect their AI agent of choice with trusted Tektronix measurement knowledge, tools and supported instruments across the portfolio.

With the 1 Series, engineers can tell their AI agent what they are trying to accomplish in plain language, then the agent can use the connector to translate that intent into validated instrument commands to directly control the instrument or build working automation. For students and educators, this creates a more intuitive way to configure and control the instrument. For experienced engineers, it can reduce the steps between identifying a problem and getting to the measurements needed to understand it.

The connector offers a first look at how Tektronix is enabling a new interaction between engineers, AI, and their instruments, informed by 80 years of measurement expertise. Request early access at dev.tek.com/en/tek-intelligence.

Availability

The 1 Series DPO is available today. See where measurement can go next at tek.com/1seriesdpo.

About Tektronix

Tektronix is the partner engineers have trusted to measure, discover and innovate for 80 years. Today we deliver test and measurement solutions that unite precision with simplicity, helping engineers accelerate breakthroughs that shape a better tomorrow. Learn more at tek.com/newsroom.

Tektronix is a registered trademark of Tektronix, Inc. All other trade names referenced are the service marks, trademarks or registered trademarks of their respective companies. Use of Tek Intelligence is subject to the end user license agreement available at https://www.tek.com/en/terms_and_conditions.

SOURCE: Tektronix, Inc.

BAIC FOTON Unveils Supercharging Strategy to Advance Global Smart Energy Ecosystem

Tue, 10 Nov 2026 20:14:00 +0700

BEIJING, Nov. 09, 2026 (GLOBE NEWSWIRE) -- On November 6, BAIC FOTON held its Supercharging Strategy Launch Event in Beijing, attended by company executives, industry partners, customers, and media representatives.

The company unveiled its integrated supercharging strategy and globally debuted the AUMARK Z supercharging light-duty truck and megawatt-level supercharging heavy-duty trucks, advancing its "Vehicle-Charger-Grid-Cloud" ecosystem.

Integrated Energy Management and Supercharging Technology

Qin Zhidong, Vice President of BAIC FOTON, outlined the strategy, highlighting opportunities in charging services, virtual power plants, battery leasing, and battery reuse.

The integrated architecture connects vehicles, charging stations, power grids, and cloud platforms for coordinated energy management. Supported by over 3.5 million connected vehicles, 3 PB of daily data processing, and 770,000 charging terminals, it enables data-driven operations.

Its 800V architecture supports up to 1,000V, 1.5MW charging power, and 1,600A dual-connector current. Batteries offer charging rates above 4C, 95% efficiency, and over 6,500 cycles, supported by thermal management technology.

Two Supercharging Models Make Global Debut

Ma Lu, President of FOTON AUV and AUMARK Business Division, introduced the AUMARK Z, presented as the world's first supercharging light-duty truck built on a dedicated electric platform. With 8C charging and 1.05MW peak power, it charges from 20% to 80% in eight minutes.

Chen Peng, Vice President of R&D at FOTON AUMAN, introduced megawatt-level heavy-duty trucks covering the AUMAN GALAXUS and CAVAN BEACON series. Six minutes of charging provides approximately 100 kilometers of range, supporting express logistics, cold-chain transportation, port operations, and bulk cargo delivery.

Expanding the Global Supercharging Ecosystem

BAIC FOTON is developing solar-storage-charging stations with 10kV AC input and 1,000V DC output, integrating power generation, storage, and energy management.

Together with CATL, Sunwoda, TELD, and Hunan Jingneng, BAIC FOTON launched a Supercharging Industry Ecosystem Alliance, targeting 5,000 standardized integrated charging stations.

Leveraging operations across 140-plus countries and regions, BAIC FOTON plans to expand charging infrastructure across Asia-Pacific, Latin America, Africa, and Europe, targeting over 3,000 overseas charging units by 2027.

Through vehicle, battery, and energy ecosystem collaboration, BAIC FOTON aims to improve logistics efficiency, reduce operating costs, and support greener commercial transportation worldwide.

YYForce's Humanoid Robotics and VLA Training Workflow Featured on Mediacorp's Meeting AI

Tue, 10 Nov 2026 20:09:00 +0700

Television feature showcases the Unitree G1 humanoid robot alongside human-in-the-loop teleoperation and Vision-Language-Action (VLA) AI training, highlighting YYForce's vision for a technology-enabled future workforce

SINGAPORE, Nov. 09, 2026 (GLOBE NEWSWIRE) -- YYForce Inc. (Nasdaq: YFOR) ("YYForce" or the "Company"), a technology-enabled provider of workforce solutions and integrated facility management services, today announced that its humanoid robotics training initiatives were featured in a dedicated television broadcast produced and aired by Mediacorp in Singapore.

The feature aired on November 6, 2026, on Mediacorp 8world's technology and current affairs program Meeting AI (《遇见AI》), in an episode titled "Can AI Learn in Just One Lesson?" (《AI-教就会？》).

Watch the full broadcast feature on YouTube: https://youtu.be/QdH6VVlspYI

Hosted by veteran presenter Zhang Haijie, the television feature provided viewers with an in-depth, hands-on look at emerging humanoid robotics technologies and their practical commercial training workflows. During the broadcast, the presenter participated directly in a teleoperation demonstration with the Unitree G1 humanoid robot, utilizing a VR head-mounted display and five precision tracking sensors fitted to the head, hands, and feet. The system mapped human movement and velocity directly onto the robot in real time, recording joint angles, kinematic positions, and visual camera feeds to build high-fidelity physical AI training datasets.

Key Technical Workflow Demonstrated in Broadcast:

Human Demonstration & Kinematic Logging: Human operators demonstrate standard physical tasks repeatedly, capturing joint actuation and visual feeds without requiring manual coordinate tagging.

Data Cleaning & Filtering: Recorded trajectories and sensor streams are curated and filtered to eliminate execution anomalies and suboptimal sample runs.

Vision-Language-Action (VLA) Training: As demonstrated in the broadcast, teaching the humanoid robot to autonomously identify, grasp, and move a cup required 40 human demonstrations and data cleaning, followed by approximately eight hours of neural network training on advanced VLA models before autonomous execution was achieved.

The broadcast illustrated the reality behind embodied artificial intelligence: making service robots operate effectively and safely in unstructured, real-world commercial environments begins with structured learning from human frontline workers.

Bringing Robotics into Real-World Service Environments

YYForce is developing its robotics strategy around practical commercial applications rather than robotics demonstrations alone. The Company is exploring applications of humanoid and specialized robotics across areas including hospitality, integrated facility management, commercial cleaning, delivery, security, and other labor-intensive service environments.

YYForce's robotics initiatives include humanoid robot training and data collection for tasks such as hotel-room and restroom cleaning and hospitality service applications, alongside specialized commercial robots designed for cleaning, delivery, and other operational functions.

The Company believes that combining human workers with AI-enabled systems and robotics could create a new model of workforce deployment in which technology supports repetitive, standardized, and physically demanding tasks while human workers concentrate on activities requiring communication, judgment, and customer interaction.

Building the Infrastructure for Human-Robot Collaboration

YYForce is developing capabilities intended to support the broader adoption of robotics in real-world service environments. In Singapore, the Company has established robotics demonstration and training capabilities where humanoid and specialized service robots can be showcased, trained, and evaluated for different operational scenarios.

These initiatives are intended to help YYForce understand how robotics technologies can be integrated into existing workforce and facility-management operations while developing the skills and operating processes required for future deployment.

Management Commentary

Mike Fu, Chief Executive Officer of YYForce, said:

"Being featured on Mediacorp provides an opportunity to show a wider audience how quickly robotics technology is moving from concept toward practical applications. The segment demonstrated the reality behind physical AI: for robots to operate reliably in commercial environments, they must first learn directly from human experience."

"Our vision is not about replacing people with robots. We are building toward an operating model where people, AI, humanoid robots and specialized service robots can work together, with each performing the functions where they can create the greatest value."

"Hospitality and facility management provide practical environments for developing these capabilities because they involve a wide range of repetitive, physical and service-oriented tasks. This hands-on training methodology is an essential component of our YYForce 2030 Vision as we continue Forging Forward Together toward the future of work."

From Workforce Provider to Future Workforce Solutions Platform

The Mediacorp feature reflects YYForce's broader transformation from its traditional workforce and facility services operations toward a technology-enabled future workforce solutions platform.

Under the Company's YYForce 2030 Vision, YYForce is developing an ecosystem that brings together:

Human workforce and on-demand staffing capabilities;

Artificial intelligence and workforce technology;

Humanoid robots and specialized service robotics;

Robotics training, data collection, and operational deployment;

IoT, sensors, and smart-building technologies; and

YYForce's 24iFM integrated facility management platform.

The long-term objective is to enable human workers, AI, and robotics to operate together within a connected service-delivery ecosystem.

About YYForce Inc.

YYForce Inc. (Nasdaq: YFOR) is a technology-enabled provider of workforce solutions and integrated facility management services. The Company is developing a future workforce ecosystem integrating human talent, artificial intelligence, humanoid and service robotics, IoT technologies, and digital facility-management platforms.

Through its workforce operations, integrated facility-management capabilities, 24iFM platform, and emerging robotics initiatives, YYForce seeks to support the transition toward technology-enabled, human-and-machine collaborative service delivery.

For more information, visit www.yyforce.ai.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on the Company's current expectations, assumptions and information available to it as of the date of this release. Forward-looking statements can be identified by words such as "may," "will," "should," "expects," "anticipates," "plans," "intends," "believes," "estimates," "potential" or similar expressions, or the negative of these terms.

Forward-looking statements in this release include, but are not limited to, YYForce's strategy and 2030 Vision, the development, training, integration and commercial adoption of its AI and robotics solutions, including humanoid robots, human-robot collaboration, customer demand, investment priorities and operating objectives.

Forward-looking statements involve inherent risks and uncertainties, and the forward-looking events discussed in this press release may not occur. Actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about the Company and a number of factors. For a more detailed discussion of risk factors, please refer to the Company's filings with the U.S. Securities and Exchange Commission, including the "Risk Factors" section of the Company's most recent annual report on Form 20-F, as amended. YYForce undertakes no obligation to update these statements except as required by applicable law.

Information contained in or accessible through the Mediacorp broadcast or any website referenced in this release is not incorporated into, and does not form part of, this press release.

PhotonPay Strengthens North American Regulatory Footprint with Canada's RPAA Registration

Tue, 10 Nov 2026 20:05:00 +0700

The registration reinforces PhotonPay's regulatory foundation for payment activities in Canada, with requirements covering operational risk management, incident response and the safeguarding of end-user funds.

HONG KONG SAR - Media OutReach Newswire - 10 November 2025 - PhotonPay today announced that its Canadian operating entity, Photon Dance CA Inc., is now registered with the Bank of Canada as a payment service provider (PSP) under Canada's Retail Payment Activities Act (RPAA).

The entity was previously registered with the Financial Transactions and Reports Analysis Centre of Canada (FINTRAC) as a Money Services Business (MSB). The RPAA registration further strengthens PhotonPay's regulatory foundation in Canada and supports its continued development of local financial services across North America.

The RPAA establishes a federal framework for the registration and supervision of PSPs conducting specified retail payment activities in Canada. Administered by the Bank of Canada, it sets requirements for operational risk management, incident response and regulatory reporting. PSPs that hold end-user funds are also required to implement measures to safeguard those funds, strengthening oversight and accountability across Canada's retail payments ecosystem.

The Canadian registration adds to PhotonPay's broader regulatory presence across North America. In the United States, PhotonPay is registered as a Money Services Business with the Financial Crimes Enforcement Network (FinCEN) and holds money transmitter licenses across multiple U.S. states. Across the Americas, Europe and Asia, PhotonPay holds 35 payment licenses, regulatory authorizations and registrations, reflecting the regulatory breadth behind its operations across key financial markets.

For PhotonPay, building a global financial operating system requires more than connecting payment capabilities across markets. It also means developing the local regulatory and financial infrastructure needed to support those capabilities in each jurisdiction. As businesses expand internationally, their financial operations increasingly span different account structures, payment systems, currencies and regulatory environments. Bringing these functions together requires infrastructure that can address local market requirements while giving businesses a more unified way to manage their global finances.

This is the vision behind PhotonPay's next-generation Financial OS. Through an integrated, API-first architecture, PhotonPay brings together multi-asset wallets, local collections, global payouts, foreign exchange, card issuing and embedded finance. By supporting both fiat currencies and stablecoins within its broader financial infrastructure, the platform connects traditional payment rails with emerging digital-asset capabilities, helping businesses manage increasingly complex financial operations across markets.

"Global financial infrastructure must be designed around the realities of the markets it serves. Regulatory frameworks, payment systems and the responsibilities involved in handling funds differ across jurisdictions, and these differences need to be accounted for at the infrastructure level," said JP Pi, Global Chief Compliance Officer at PhotonPay. "Our approach is to build a Financial OS that brings together global capabilities while respecting the regulatory and operational requirements of each local market. The RPAA registration is another step in putting that approach into practice, as we continue developing infrastructure to support businesses operating across an increasingly interconnected financial landscape."

About PhotonPay

Founded in Hong Kong in 2015, PhotonPay is a global fintech company building a next-generation, stablecoin-centric Financial Operating System (Financial OS). Its API-first architecture brings together multi-asset wallets supporting stablecoins and fiat currencies, global money movement, foreign exchange, global card issuing, embedded finance, and local clearing infrastructure, connecting digital and traditional financial rails within an integrated financial system.

PhotonPay operates 16 offices worldwide, employs nearly 600 people, and holds 35 payment and financial licenses and regulatory authorizations across the Americas, Europe and Asia. The company serves businesses across more than 200 countries and territories.

For more information, visit www.photonpay.com.

The issuer is solely responsible for the content of this announcement.

Hashtags: #PhotonPay

https://www.photonpay.com

*Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable ..............

Tue, 10 Nov 2026 19:57:00 +0700

*Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits

*SYNCHRONIZE-CVOT met its primary endpoint demonstrating the safety of survodutide in terms of major adverse cardiovascular events compared with placebo in people with obesity and established cardiovascular disease (CVD), chronic kidney disease, and/or at least two weight-related complications or risk factors for CVD.1

*Survodutide also demonstrated meaningful improvements across multiple cardiometabolic measures, including significant reductions in systolic blood pressure and waist circumference at 72 weeks vs placebo.1

*These results were presented today at the American Heart Association Scientific Sessions and simultaneously published in the Lancet.2

Ingelheim, Germany - Boehringer Ingelheim today announced positive results from the Phase III SYNCHRONIZE-CVOT trial, the first and only global cardiovascular safety trial of a glucagon/GLP-1 dual agonist to date. The trial met its primary endpoint using both the treatment-regimen* and supplementary secondary estimands?.

The trial demonstrated that survodutide (BI 456906) did not increase the risk of major adverse cardiovascular events (5P-MACE: cardiovascular death, non-fatal MI, non-fatal stroke, coronary revascularization, or heart failure events) compared to placebo (HR 0.89 [95% CI: 0.67-1.18]; p<0.0001 for non-inferiority using the treatment-regimen estimand) in adults living with obesity or overweight with established cardiovascular disease (CVD), chronic kidney disease, and/or at least two weight-related complications or risk factors for CVD.1 Obesity is a chronic, complex metabolic disease with impacts extending far beyond the scale.3 Obesity is closely linked to metabolic dysfunction, increased cardiometabolic risk and with that to overall metabolic health.3,4,5 Full results from SYNCHRONIZE-CVOT were presented today at the American Heart Association's (AHA) Scientific Sessions 2026 in Chicago, Illinois and simultaneously published in the Lancet2. An additional publication focused on achievement of cardiometabolic treatment targets will also be presented at AHA.6

Key secondary endpoint results showed that survodutide did not increase the risk of cardiovascular death, non-fatal stroke or non-fatal MI (3P-MACE) compared to placebo (HR 0.84 [95%CI: 0.60-1.18]; p<0.0001 for non-inferiority using the treatment -regimen estimand).1

Additional key secondary endpoints showed survodutide improved several cardiometabolic health markers. A reduction in systolic blood pressure by up to 6.68 mmHg was seen using the supplementary secondary estimand compared with 1.76 mmHg in those receiving placebo (P= 0.0001), at 72 weeks.1 Cardiovascular disease represents a leading cause of mortality and morbidity in people living with obesity.7 For those receiving survodutide, a reduction in waist circumference of up to 11.96 cm was seen using the supplementary secondary estimand vs 2.74 cm with placebo.

This reduction of waist circumference serves as a clinical marker closely linked to visceral fat and cardiometabolic risk.5 Secondary endpoint results showed survodutide delivered meaningful weight loss of up to 13.7% at Week 72 using the supplementary secondary estimand in a population at elevated cardiovascular risk including individuals with T2D versus 2.0% in the placebo arm.1 Significant reductions were seen in additional metabolic health biomarkers such as the inflammatory marker high sensitivity C-reactive protein (hs-CRP) and triglycerides versus placebo, that are predictors of cardiovascular risk.2,8 Together, these findings demonstrate improvements across several dimensions of cardiometabolic health while establishing cardiovascular safety consistent with placebo.

"For people living with obesity, the clinical challenge extends beyond weight to the profound, often unrecognized effects of obesity, on cardiovascular and metabolic health," said Dr. Biykem Bozkurt, M.D., Ph.D., Principal Investigator of the SYNCHRONIZE-CVOT trial. "We are looking at novel therapeutic approaches that do not merely reduce body weight but can also improve metabolic dysfunction while maintaining cardiovascular safety. Combined with the breadth of evidence from the SYNCHRONIZE program, these data help give us confidence in how we could manage obesity and related cardiometabolic risk."

Obesity is a chronic, complex metabolic disease that can contribute to metabolic dysfunction, which can develop silently and progressively increase the likelihood of cardiometabolic conditions such as type 2 diabetes, cardiovascular disease, chronic kidney disease and MASLD/MASH.3,4,5,9 Survodutide's dual glucagon/GLP-1 receptor agonist mechanism is designed to address this with the GLP-1 receptor agonism helping to regulate appetite and energy intake, while it's glucagon receptor agonism is associated with effects on energy expenditure and liver metabolism.10,11,12,13 By addressing these interconnected factors, survodutide may have the potential to deliver benefits that extend beyond weight loss to broader metabolic health. Survodutide has not been approved for use, and its efficacy and safety have not been established. Based on the totality of evidence generated across the SYNCHRONIZE program, we are moving forward with preparations for regulatory submissions in obesity.

"The SYNCHRONIZE-CVOT trial findings represent an important milestone for survodutide clinical development as this is the first time we have demonstrated survodutide safety with respect to major adverse cardiovascular events," said Shashank Deshpande, Chairman of the Board of Managing Directors and Head of Human Pharma, Boehringer Ingelheim. "Together with the growing body of evidence from the SYNCHRONIZE program, these results strengthen our confidence in the potential of survodutide's dual-agonist approach to address underlying metabolic dysfunction and improve broader metabolic health beyond body weight alone. We remain committed to building evidence across interconnected metabolic diseases through our broader global clinical development program."

As expected with GLP-1-based therapies, the most commonly reported adverse events for survodutide were gastrointestinal (GI) events, which were mostly mild to moderate in severity, with nausea, vomiting, diarrhea, and constipation the most common compared to placebo.1 The treatment discontinuation rates due to GI adverse events were 19.3% and 20.8% in people who received 3.6mg and 6.0mg doses of survodutide respectively compared to 1.9% on the placebo arm. These results are consistent with those from other SYNCHRONIZE trials.1

Discontinuations usually occurred during the dose escalation phase, as the initial study protocol allowed limited flexibility to manage adverse events through slower titration, dose adjustment, or longer temporary interruption.1 This resulted in discontinuation in situations where patients might otherwise have continued treatment. Upcoming Phase IIIb studies, including SYNCHRONIZE-START, SYNCHRONIZE-HERA, and ELEVATE-LIVER, as well as the Phase III SYNCHRONIZE-T2D trial, allow for more flexible, patient‑centered titration strategies from the start to better reflect real‑world use and support tolerability.14,15,16,17

In addition to the SYNCHRONIZE program, survodutide is being studied in two global Phase III clinical trials LIVERAGE and LIVERAGE-Cirrhosis investigating the efficacy and safety of survodutide in adults with MASH and fibrosis stages 2 or 3 and in those with compensated MASH cirrhosis (fibrosis stage 4).18,19

* The treatment-regimen estimand is the estimated treatment effect, regardless of whether the patient adheres to the treatment, discontinues, or initiates other therapies.

? The supplementary secondary estimand is the effect expected with continued treatment, assuming no intercurrent events. It is conceptually similar to the efficacy estimand used in the other SYNCHRONIZE trials.

About obesity and overweight

More than one billion people around the world are living with obesity today (1 in 8 of us) - and by 2030, that number could be more than double what it was in 2010.20 Overweight and obesity are complex chronic conditions involving abnormal or excessive fat accumulation that present a risk to a person's overall health.21

About survodutide (BI 456906)

Survodutide is a glucagon/GLP-1 receptor dual agonist that activates both the glucagon and GLP-1 receptors, which play a role in controlling metabolic functions.12,22,23 Survodutide is an investigational agent and has not been approved for use; its efficacy and safety has not been established. It is being evaluated in a robust Phase III clinical development program, including the SYNCHRONIZE studies for people living with overweight or obesity, and the LIVERAGE studies for people living with MASH and fibrosis.17,18,19,24,25,26,27,28,29

Survodutide has potential to treat adults with non-cirrhotic MASH and moderate or advanced fibrosis (stages 2 or 3) and has been recognized by the U.S. FDA, which granted it:

Fast Track designation in May 2021 and;30

Breakthrough Therapy designation in September 2024.31

Survodutide's potential to treat adults with MASH and fibrosis has also been recognized by:

the European Medicines Agency (EMA), through acceptance to its PRIME scheme in November 2023 and;32

the Center for Drug Evaluation of China's National Medical Products Administration (NMPA) which granted it Breakthrough Therapy designation in June 2024 and;

the Taiwan Food and Drug Administration which granted it Breakthrough Designation in September 2024.

Survodutide is licensed to Boehringer Ingelheim from Zealand Pharma, with Boehringer solely responsible for development and commercialization globally. Survodutide is part of Boehringer Ingelheim's research and development portfolio in the cardiovascular, renal and metabolic disease areas.

About the SYNCHRONIZE-CVOT trial (NCT06077864)

SYNCHRONIZE-CVOT is a Phase III, double-blind, placebo-controlled event driven cardiovascular safety study of survodutide among 5530 adults living with obesity or overweight with established cardiovascular disease (CVD) or chronic kidney disease, and/or at least two weight-related complications or risk factors for CVD.27 Participants received a weekly injection of survodutide at either a 3.6 mg or 6.0 mg dose, or placebo. The primary endpoint of the trial is the time to first occurrence of any of the adjudicated components of the composite endpoint consisting of: CV death, non-fatal stroke, non-fatal MI, ischaemia related coronary revascularisation, or HFE (to demonstrate non-inferiority).27

There are 27 secondary and key secondary endpoints, including:27

Time to first occurrence of any of the adjudicated components of 3P-MACE (CV death, non-fatal stroke, or non-fatal MI)

Absolute change in systolic blood pressure (SBP)

Absolute change in waist circumference

Percentage change in body weight

About the SYNCHRONIZE program

Survodutide has been evaluated in three other global Phase III studies for people living with overweight or obesity.

SYNCHRONIZE-1 enrolled adults without type 2 diabetes.24

SYNCHRONIZE-MASLD enrolled adults at risk of MASLD with a confirmed or presumed diagnosis of MASH.26

SYNCHRONIZE-2 enrolled adults with type 2 diabetes.25

Survodutide is also explored in two Phase III in-market trials:

SYNCHRONIZE-JP in Japan and SYNCHRONIZE-CN in China are exploring survodutide for sub-populations of people living with obesity. SYNCHRONIZE-JP explores the relative change in liver fat and body composition parameters from baseline to Week 76 when treated with survodutide versus placebo, as a secondary endpoint.28,29

As part of the broader evidence program, a set of Phase IIIb studies are being advanced to address key unmet needs in people living with obesity and real-world care, including:

SYNCHRONIZE-HERA will evaluate survodutide in women's health.15

ELEVATE-LIVER will assess the impact of survodutide in the preservation of cardiac function and structure in people living with metabolic dysfunction-associated steatotic liver disease (MASLD) or early metabolic dysfunction-associated steatohepatitis (MASH).16

SYNCHRONIZE-START will examine real-world titration approaches, including treatment initiation and switching from GLP-1 RAs, with a focus on tolerability.14

Additionally, SYNCHRONIZE-T2D will investigate the effect of survodutide on improving glycemic control in adults with T2D who are managing their condition with diet and exercise alone or in combination with diabetes medications, including insulin.17

About LIVERAGE and LIVERAGE-Cirrhosis

LIVERAGE and LIVERAGE-Cirrhosis are global Phase III clinical trials investigating the efficacy and safety of survodutide in adults with MASH and fibrosis stages 2 or 3 and in those with compensated MASH cirrhosis (fibrosis stage 4), respectively.18,19

LIVERAGE will enroll approximately 1,800 adults, and LIVERAGE-Cirrhosis will enroll approximately 1,590 adults. In each trial, participants are randomized to receive weekly injections of either survodutide, reaching a maximum dose, or placebo.18,19

About Boehringer Ingelheim

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective. Our approximately 54,300 employees serve over 130 markets to build a healthier tomorrow. Learn more at www.boehringer-ingelheim.com.

Boehringer Ingelheim's Intended Audiences Notice

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.

References

1Bozkurt B. "Survodutide and cardiovascular outcomes in obesity: Results from the SYNCHRONIZE-CVOT trial" Oral presentation at the American Heart Association 2026, Chicago, Illinois. 9 November 2026.

2Bozkurt B, et al. Cardiovascular outcomes with survodutide in adults with obesity at increased cardiovascular risk (SYNCHRONIZE-CVOT): a double-blind, randomised, phase 3 trial. The Lancet. 2026. doi: 10.1016/S0140-6736(26)02140-9.

3Centers for Disease Control and Prevention (CDC). Consequences of obesity. Published December 5, 2025. Accessed October, 2026.

4Wharton S et al. CMAJ 2020

5Busetto L, et al. Nat Med 2024

6Bozkurt B. "Cardiometabolic effects of survodutide in participants with obesity and cardiovascular disease" Oral presentation at the American Heart Association 2026, Chicago, Illinois. 9 November 2026.

7Abdelaal M, et al. Ann Transl Med. 2017 Apr;5(7):161. doi: 10.21037.

8Sharma A,et al. Healthcare (Basel). 2022 Feb 7;10(2):312. doi: 10.3390/healthcare10020312.

9Rubino F, et al. Lancet Diabetes Endocrinol. 2025 Mar;13(3):221-262. doi: 10.1016/S2213-8587(24)00316-4.

10Arun A, et al. Cardiology in Review. Survodutide: A Dual GLP-1/Glucagon Agonist Reshaping Cardiometabolic Care [Internet]. Available from: https://journals.lww.com/cardiologyinreview/abstract/9900/survodutide__a_dual_glp_1_glucagon_agonist.598.aspx. Last accessed: September 2026.

11Shah M, Vella A. Rev Endocr Metab Disord. 2014;15(3):181-187.

12Sanyal AJ, et al. N Engl J Med. 2024;391(4):311-319.

13Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E671-8.

14Clinicaltrials.gov. SYNCHRONIZE-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight. Available at: https://clinicaltrials.gov/study/NCT07855900. Last accessed: October2026.

15Clinicaltrials.gov. SYNCHRONIZE-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight. Available at: https://clinicaltrials.gov/study/NCT07850050. Last accessed: October2026.

16Clinicaltrials.gov. ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease. Available at: https://clinicaltrials.gov/study/NCT07850063. Last accessed: October2026.

17Clinicaltrials.gov. A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar. Available at: https://clinicaltrials.gov/study/NCT07754461. Last accessed: September 2026.

18Clinicaltrials.gov. LIVERAGE: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis. Available at: https://clinicaltrials.gov/study/NCT06632444. Last accessed: September 2026.

19Clinicaltrials.gov. LIVERAGE - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis. Available from: https://clinicaltrials.gov/study/NCT06632457. Last accessed: September 2026.

20World Heart Federation. Obesity. 2015. Available at: https://world-heart-federation.org/what-we-do/obesity. Last accessed September 2026.

21Bray A, et al. Obes Rev 2017;18:715-723.

22Arun AJ, Daet al. Rev. 2025 Sep 18. doi: 10.1097/CRD.0000000000001062.

23Novikoff A. Peptides 2023; 165:171003.

24Clinicaltrials.gov. A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight (SYNCHRONIZE-1). Available at: https://clinicaltrials.gov/study/NCT06066515. Last accessed: September 2026.

25Clinicaltrials.gov. A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight (SYNCHRONIZE-2). Available at: https://clinicaltrials.gov/study/NCT06066528. Last accessed: September 2026.

26Clinicaltrials.gov. A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight. Available at: https://clinicaltrials.gov/study/NCT06309992. Last accessed: September 2026.

27Clinicaltrials.gov. A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE - CVOT). Available at: https://clinicaltrials.gov/study/NCT06077864. Last accessed: September 2026.

28Clinicaltrials.gov. A Study to Test Whether BI 456906 Helps Japanese People Living With Obesity Disease (SYNCHRONIZEJP). Available at: https://clinicaltrials.gov/study/NCT06176365. Last accessed: September 2026.

29Clinicaltrials.gov. A Study to Test Whether BI 456906 Helps Chinese People Living With Overweight or Obesity to Lose Weight. Available at: https://clinicaltrials.gov/study/NCT06214741. Last accessed: September 2026.

30"Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH." Boehringer Ingelheim. www.boehringer-ingelheim.com/us/press-release/boehringer-ingelheim-and-zealand-pharma-receive-fda-fast-track-designation. Last accessed: September 2026.

31Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide. Boehringer Ingelheim. Available at: www.boehringer-ingelheim.com/human-health/metabolic-diseases/survodutide-us-fda-breakthrough-therapy-phase-3-trials-mash. Last accessed: September 2026.

32"List of medicines currently in PRIME scheme." European Medicines Agency. December 2023. Available at: www.ema.europa.eu/en/documents/other/list-medicines-currently-prime-scheme_en.xlsx. Last accessed: September 2026.

Curia Expands Fermentation Capacity in Leon, Spain

Tue, 10 Nov 2026 19:52:00 +0700

The 5-million-euro investment will strengthen fermentation and downstream processing operations

ALBANY, N.Y., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Curia Global Inc. (Curia), a global contract research, development and manufacturing organization (CDMO), today announced the completion of its 5-million-euro investment in its Leon, Spain operations. The project supports a new precision fermentation facility for development and scale-up activities through capacity enablement and upgraded site utilities.

As part of the initiative, Curia built a facility with fermentation (USP) and downstream processing (DSP) equipment to enable optimized manufacturing flows. To fully support the new production building, the project includes the installation of critical utility systems. These upgrades are designed to provide a reliable utility supply across production operations. New equipment installations will increase the facility's capacity to 58,000 L.

"Curia is committed to supporting customers with reliable, efficient manufacturing and flexible capacity as programs advance," said Jamie Grabowski, President of R&D at Curia. "By aligning our equipment footprint and upgrading essential utilities, we are building a strong foundation for sustained performance at Le?n."

Curia's Le?n facility specializes in biotechnology development, fermentation production and downstream processing for customers across the pharmaceutical, cosmetic, agriculture and food industries. This expansion reflects Curia's continued focus on strengthening its manufacturing network and ensuring that sites are equipped to meet evolving customer needs through dependable operations and high standards of quality.

About Curia

Curia is a contract research, development and manufacturing organization (CDMO) with an integrated network of 20+ global sites and 3,000+ employees supporting biopharmaceutical customers from discovery through commercialization. Our capabilities span small molecules, generic APIs and biologics, with expertise in regulatory support, analytical services, drug substance and sterile fill-finish manufacturing.

Founded in 1991 as Albany Molecular Research, Inc. (AMRI), Curia built its foundation on scientific innovation and was originally known for the discovery and development of the active pharmaceutical ingredient in Allegra. Over the last three decades, we expanded our capabilities and global footprint through strategic acquisitions, including Crystal Pharma, Euticals, Gadea Pharmaceutical Group, Integrity Bio, LakePharma and Ragactives.

Today, Curia partners with customers to accelerate discovery, development and manufacturing timelines to help bring life-changing therapies to patients. Visit us at curiaglobal.com.

Curia Memperluas Kapasitas Fermentasi di Leon, Spanyol

Tue, 10 Nov 2026 19:48:00 +0700

Investasi senilai 5 juta euro ini akan memperkuat kegiatan operasional fermentasi dan pengolahan hilir

ALBANY, N.Y., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Curia Global Inc. (Curia), perusahaan penelitian, pengembangan, dan manufaktur berbasis kontrak (CDMO) global, hari ini mengumumkan penyelesaian investasi senilai 5 juta euro untuk kegiatan operasionalnya di Leon, Spanyol.

Proyek ini mendukung fasilitas fermentasi presisi baru untuk kegiatan pengembangan dan peningkatan skala produksi melalui penyediaan sarana pendukung kapasitas serta peningkatan fasilitas utilitas di lokasi.

Sebagai bagian dari inisiatif ini, Curia membangun fasilitas yang dilengkapi dengan peralatan fermentasi (USP) dan pengolahan hilir (DSP) untuk mendukung alur proses manufaktur yang optimal. Untuk mendukung sepenuhnya gedung produksi baru, proyek ini mencakup pemasangan sistem utilitas penting. Peningkatan ini dirancang untuk menyediakan pasokan utilitas yang andal di seluruh kegiatan operasional produksi. Pemasangan peralatan baru akan meningkatkan kapasitas fasilitas menjadi 58.000 L.

"Curia berkomitmen untuk mendukung pelanggan melalui proses manufaktur yang andal dan efisien serta kapasitas yang fleksibel sejalan dengan perkembangan program," ujar Jamie Grabowski, Presiden Litbang di Curia. "Dengan menyesuaikan kebutuhan ruang peralatan kami dan meningkatkan sistem utilitas penting, kami membangun fondasi yang kuat untuk mendukung kinerja berkelanjutan di Leon."

Fasilitas Curia di Le?n memiliki spesialisasi dalam pengembangan bioteknologi, produksi fermentasi, dan pengolahan hilir bagi pelanggan di industri farmasi, kosmetik, pertanian, dan pangan. Ekspansi ini mencerminkan fokus berkelanjutan Curia dalam memperkuat jaringan manufakturnya. Langkah ini juga memastikan setiap fasilitasnya dilengkapi dengan sarana memadai untuk memenuhi kebutuhan pelanggan yang terus berkembang melalui kegiatan operasional yang andal dan standar kualitas yang tinggi.

Tentang Curia

Curia adalah perusahaan penelitian, pengembangan, dan manufaktur berbasis kontrak (contract research, development and manufacturing organization/CDMO) dengan jaringan terpadu yang mencakup lebih dari 20 lokasi global dan didukung oleh lebih dari 3.000 karyawan. Curia mendukung pelanggan biofarmasi mulai dari tahap penemuan hingga komersialisasi. Kapabilitas kami mencakup molekul kecil, API generik, dan produk biologis, dengan keahlian dalam dukungan regulasi, layanan analitik, manufaktur bahan obat, serta pengisian dan penyelesaian akhir secara steril.

Didirikan pada tahun 1991 dengan nama Albany Molecular Research, Inc. (AMRI), Curia berkembang dengan berlandaskan inovasi ilmiah dan pada awalnya dikenal atas penemuan serta pengembangan bahan aktif farmasi (API) yang digunakan dalam obat alergi Allegra. Selama tiga dekade terakhir, kami telah meningkatkan kapabilitas dan kehadiran kami di pasar global melalui sejumlah akuisisi strategis, termasuk Crystal Pharma, Euticals, Gadea Pharmaceutical Group, Integrity Bio, LakePharma, dan Ragactives. Saat ini, Curia bermitra dengan pelanggan untuk mempercepat proses penemuan, pengembangan, dan manufaktur guna membantu menghadirkan terapi yang dapat mengubah kehidupan pasien. Kunjungi kami di curiaglobal.com.

Acronis Debuts First TRU Cyber Pulse Report, Mapping Modern Cyber Threats in 2026 and Beyond

Tue, 10 Nov 2026 06:55:00 +0700

Inaugural report examines AI-enabled attacks, cybercrime trends, and evolving ransomware tactics, drawing on year-round research

SCHAFFHAUSEN, Switzerland, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Acronis, a global provider of an AI-native cyber platform for MSPs and IT departments, today announced the release of the inaugural Acronis TRU Cyber Pulse 2026, a report from the Acronis Threat Research Unit (TRU) examining threat actor techniques, behaviors, and objectives shaping today's cybersecurity and data protection landscape.

The first edition examines emerging attack techniques, advanced persistent threats (APTs), espionage activity, and cybercrime. It connects research findings to practical guidance, with particular attention to managed service providers (MSPs) and the organizations they support. The report's central message is that a compromised device or identity can provide access well beyond the initial point of entry, and that understanding those connections is essential to detecting, containing, and recovering from attacks.

Key findings include:

AI can help a single operator coordinate sophisticated operations. In its BOSSAI investigation, TRU found that one operator used AI agents for reconnaissance, exploitation, and infrastructure management while pursuing targets across multiple countries.

Infostealers put identities and connected services at risk. Stolen credentials, sessions, tokens and API keys can extend an endpoint infection into cloud services, development environments and other connected systems.

Attackers are deliberately disabling security controls. Ransomware operators and advanced threat groups use defense impairment techniques to disrupt endpoint protection and logging, creating blind spots as they move through an environment.

The time to respond to newly disclosed vulnerabilities is shrinking. AI-assisted attackers can develop and weaponize exploits in a matter of hours, increasing the urgency of assessing and patching exposed systems.

Trusted services can become part of attack infrastructure. Threat actors use familiar platforms such as GitHub and Telegram to host or direct malicious activity, making it harder to distinguish abuse from legitimate use.

Ransomware is reaching deeper into enterprise infrastructure. Linux and VMware ESXi systems are increasingly targeted, exposing workloads and services that organizations depend on.

A compromise can have an expanded impact on MSPs and their clients. Administrative identities, remote management tools and shared infrastructure can connect multiple customer environments.

The Acronis TRU Cyber Pulse 2026 report underscores why security teams need to investigate the reach of a compromised identity or system, not only the original device. For MSPs, a single compromised account or management tool may put multiple client environments at risk. The findings also highlight the value of maintaining visibility into identity and cloud activity, limiting the permissions of AI agents, monitoring for disabled defenses, and testing recovery plans.

"The inaugural Cyber Pulse report reflects the breadth of TRU's work throughout the year, from analyzing malware and campaigns to tracking how threat actors adapt their operations," said Santiago Pontiroli, Threat Intelligence Research Lead at Acronis. "Looking across those investigations helps reveal patterns that can be harder to see in any single incident. The biggest trend we've noticed is how AI is helping capable operators coordinate more of the attack lifecycle, while stolen identities and trusted tools can help them move through connected environments. Defenders need to consider those risks together, from the first alert through containment and recovery."

As the Acronis TRU has expanded its research, the team regularly publishes findings that have drawn attention from the global cybersecurity community, other research teams, and media worldwide. By sharing its findings publicly, TRU contributes to the security industry by sharing insights around emerging threats and supports the exchange of intelligence to help security leaders, IT teams, and MSPs understand threats that may affect their environments. TRU also arms researcher and practitioner peers with insights to build on in their own research and defensive work.

The inaugural TRU Cyber Pulse report synthesizes findings from investigations into significant cyber incidents, malware campaigns, and threat actors to provide a comprehensive overview of the 2026 threat landscape and emerging trends. Viewed collectively, these investigations reveal broader patterns and their implications for organizations.

"Organizations rely on interconnected identities, tools and services, and attackers know how to exploit those connections," said Gerald Caron, CISO at Acronis. "This report reinforces that protecting individual endpoints alone is not enough. IT teams need visibility across identity, cloud, and remote management activity, along with MDR capabilities and recovery plans that account for compromised administrative access. An AI-native platform that unifies protection, management, and automation can give businesses a clearer view across their environments, strengthen access controls, and support a faster, more coordinated response that helps MSPs and their clients contain incidents and recover with confidence."

To learn more about the report and its findings, visit the Acronis blog here: https://www.acronis.com/en/blog/posts/beyond-data-inside-the-attacks-introducing-acronis-tru-cyber-pulse-2026/.

The Acronis TRU Cyber Pulse 2026 report will be available to download for free beginning on Monday, November 9, at https://www.acronis.com/en/resource-center/resource/acronis-tru-cyber-pulse-2026/.

About Acronis:

Acronis is a leader in AI-native cyber protection, unifying data protection, cybersecurity, IT operations and hybrid infrastructure to deliver business continuity, security and compliance with less cost and complexity. More than 21,000 service providers trust Acronis to protect over 750,000 businesses in 150 countries. Acronis is headquartered in Schaffhausen, Switzerland. For more information, visit www.acronis.com.

Octave introduces Attune Facilities, bringing AI-powered facilities management and spatial intelligence to complex multi-site operations

Tue, 10 Nov 2026 06:50:00 +0700

HUNTSVILLE, Ala., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Octave Intelligence plc (Nasdaq: OCTV), a global leader in software for the world's most mission-critical facilities and infrastructure, today announced the immediate availability of Octave Attune Facilities, a cloud-based facilities management solution for organizations managing multiple sites.

Octave Attune Facilities includes AI tools to help facilities teams operate more efficiently across complex, multi-site environments.

This release includes a built-in AI assistant for all SaaS subscriptions, enabling users to find product and process information through natural-language questions. Organizations can also extend those capabilities to query approved operational data, work orders, asset records, inventory information and technical documentation.

"Facilities teams are under increasing pressure to maintain service levels, control costs and meet compliance requirements across growing portfolios," said Joe Nichols, Vice President of Product Management - Operate, Octave. "Attune Facilities helps organizations make informed decisions and give technicians access to the information they need in the field."

Octave Attune Facilities brings together building, space, maintenance and operational data in a single system, helping facilities teams manage assets, plan work and monitor performance across their portfolios. The solution is used in government, retail, hospitality, healthcare, professional services and transportation.

Organizations are able to track costs alongside asset conditions and maintenance history to improve operations. Attune Facilities also helps provide critical context for workers and organizations through mobile tools and access to digital twins, reality capture and other visualizations.

FOR MORE INFORMATION, CONTACT:

Investors: Elizabeth Chwalk, VP, Investor Relations, elizabeth.chwalk@octave.com

Media: media@octave.com

About Octave

Octave provides mission-critical software that empowers organizations to make informed decisions across every stage of the asset lifecycle - Design, Build, Operate and Protect - where performance, safety and reliability are non-negotiable and failure is not an option.

Turning complex operational data into actionable intelligence, Octave connects expertise, real-world conditions and enterprise-scale insight to improve performance, resilience and incident response where it matters most.

Octave has approximately 7,200 employees in 45 countries. Learn more at octave.com and follow us on LinkedIn.

CNH Industrial N.V. Reports Third Quarter 2026 Results

Tue, 10 Nov 2026 06:35:00 +0700

Consolidated revenues for the third quarter of 2026 were $4.4 billion, approximately flat year over year

Reported Net income was $35 million, including a $156 million non-cash charge to establish a valuation allowance against deferred tax assets; Adjusted Net income(1) was $205 million, compared with $109 million in the prior-year quarter

Third quarter diluted EPS of $0.02 and adjusted diluted EPS(1) of $0.16

Full year guidance updated with expected IEEPA tariff refund impacts net of one-off uses

Announced earlier today an agreement with Kobelco regarding CNH Construction business

Basildon, UK - November 9, 2026 - CNH Industrial N.V. (NYSE: CNH) reported Net income for the three months ended September 30, 2026, of $35 million, or $0.02 per basic and diluted share, compared with Net income of $67 million, or $0.06 per basic and diluted share, for the three months ended September 30, 2025. Adjusted Net income(1) for the third quarter of 2026 was $205 million, compared with $109 million in the third quarter of 2025. The 2026 results include $109 million in pre-tax IEEPA tariff refunds recognized during the quarter.

Consolidated revenues for the third quarter of 2026 were $4.35 billion, and Net Sales of Industrial Activities were $3.68 billion, both essentially in line with the third quarter of 2025.

Net cash provided by operating activities was $686 million, and Free cash flow used in Industrial Activities was $10 million in Q3 2026.

Income tax expense was $204 million ($1 million in Q3 2025) with an effective tax rate ("ETR") of 89.9% (2.0% in Q3 2025). The adjusted ETR(1) was 20.6% for the third quarter of 2026 (14.0% in Q3 2025). Results for the third quarter of 2026 included a $156 million non-cash valuation allowance charge against Financial Services' deferred tax assets in Brazil, which adversely impacted reported Net income and the ETR for the quarter.

"The combination of our third quarter results and our agreement with Kobelco regarding our Construction Equipment business reflect clear progress in the execution of our strategy," said Gerrit Marx, Chief Executive Officer of CNH. "Stronger quality performance, supply chain focus, and operational efficiencies reflect disciplined execution in a challenging market environment, reinforcing our underlying business as we track our 2030 long-term value creation targets. We reinvested approximately 35% of tariff refunds received in the quarter in selective time-limited one-time efforts to clear aged inventory and accelerate our transformation. Our Agriculture segment used almost half of its refunds received in Q3 and will have reinvested over 90% by year end in discrete time-limited priorities. Although current conditions in EMEA and Brazil remain volatile, improving cycle indicators in North America reinforce our confidence in the path ahead."

Marx continued, "We continue our rigorous execution, prudent production planning, and building a stronger, more competitive CNH for the cycle dynamics ahead. CNH's agreement with Kobelco follows a deliberate process to strengthen our construction business and sharpen our focus on our agriculture business. The transaction positions CNH as the largest pure-play agriculture machinery OEM, with the ability to invest organically and inorganically as the agriculture industry moves toward recovery."

2026 Third Quarter Results

	US-GAAP
(All amounts in millions of dollars, except per share data)	Q3 2026	Q3 2025	Change	Change at c.c.(2)
Consolidated revenues	4,354	4,399	(1)%	(1)%
of which Net sales of Industrial Activities	3,684	3,702	-%	(1)%
Net income	35	67	(48)%
Diluted EPS	0.02	0.06	(0.04)
Cash flow provided by operating activities	686	659	+27

	NON-GAAP(1)
(All amounts in millions of dollars, except per share data)	Q3 2026	Q3 2025	Change
Adjusted EBIT of Industrial Activities	202	104	+94%
Adjusted EBIT Margin of Industrial Activities	5.5%	2.8%	+270 bps
Adjusted Net income	205	109	+88%
Adjusted diluted EPS $	0.16	0.08	+0.08
Free cash flow used in Industrial Activities	(10)	(188)	+178

	Agriculture
(All amounts in millions of dollars)	Q3 2026	Q3 2025	Change	Change at c.c.(2)
Net sales	2,907	2,963	(2)%	(2)%
Adjusted EBIT	173	137	+26%
Adjusted EBIT margin(1)	6.0%	4.6%	+140 bps

In North America, third quarter industry sales volume was down 12% year-over-year for tractors under 140 HP and down 5% for tractors over 140 HP; combines were down 13%. In Europe, Middle East and Africa ("EMEA"), tractor and combine demand were down 4% and 3%, respectively. South America saw tractor and combine demand decline 22% and 19%, respectively. In Asia Pacific, tractor demand decreased 4%, while combine demand increased 76%.

Agriculture net sales decreased 2% to $2.9 billion in the quarter, driven by lower volumes in South America and EMEA, partially offset by growth in Asia Pacific and by favorable price realization.

Agriculture adjusted EBIT increased to $173 million from $137 million in Q3 2025, and adjusted margin increased 140 basis points to 6.0%. The improvement primarily reflects IEEPA tariff refunds recognized during the quarter and better quality-related costs, partially offset by lower volumes in South America and EMEA.

	Construction
(All amounts in millions of dollars)	Q3 2026	Q3 2025	Change	Change at c.c.(2)
Net sales	777	739	+5%	+5%
Adjusted EBIT	65	14	+364%
Adjusted EBIT margin(1)	8.4%	1.9%	+650 bps

Global industry sales volume for construction equipment increased 13% year-over-year in the third quarter for Heavy equipment and 6% for Light equipment. Aggregated demand increased 10% in North America, 5% in EMEA, 14% in South America, and 10% in Asia Pacific.

Construction net sales increased 5% to $777 million in the quarter, driven by higher volumes in North America, partially offset by lower volumes in South America.

Construction adjusted EBIT increased to $65 million from $14 million in Q3 2025, primarily reflecting the benefit of IEEPA tariff refunds recognized during the quarter and lower SG&A expenses, partially offset by lower volumes in South America.

	Financial Services
(All amounts in millions of dollars)	Q3 2026	Q3 2025	Change	Change at c.c.(2)
Total Revenues	665	684	(3)%	(4)%
Net income (loss)	(77)	47	(264)%
Adjusted Net income(1)	79	46	+72%
Equity at quarter-end	2,756	2,896	(140)
Retail loan originations	2,483	2,657	(174)

Financial Services revenues decreased 3% in the quarter, mainly due to lower volumes in South America and North America and lower yields in most regions. The decrease was partially offset by favorable currency translation and higher used equipment sales driven by increased operating lease maturities and early payoffs.

Financial Services recorded a net loss of $77 million, compared with net income of $47 million in Q3 2025. The current quarter results primarily reflected a $156 million non-cash valuation allowance charge against deferred tax assets in Brazil, unfavorable currency translation impacts, and lower volumes in South America and North America, partially offset by lower risk costs in South America. Adjusted Net income, which excludes the valuation allowance charge, increased to $79 million from $46 million in Q3 2025.

The managed portfolio (including unconsolidated joint ventures) was $27.8 billion as of September 30, 2026 (of which retail was 70% and wholesale was 30%), down $0.7 billion compared to September 30, 2025 (down $0.7 billion on a constant currency basis(2)).

As of September 30, 2026, the receivable balance greater than 30 days past due, as a percentage of receivables, was 4.1% (3.5% as of September 30, 2025), due to economic factors impacting farmers, specifically in South America.


Results for the Nine Months Ended September 30, 2026

	US-GAAP
(All amounts in millions of dollars)	YTD Q3 2026	YTD Q3 2025	Change	Change at c.c.(2)
Consolidated revenues	12,983	12,938	-%	(2)%
of which Net sales of Industrial Activities	10,997	10,895	+1%	(1)%
Net income	186	416	(55)%
Diluted EPS $	0.14	0.34	(0.20)
Cash flow provided by operating activities	866	1,593	(727)

	NON-GAAP(1)
(All amounts in millions of dollars)	YTD Q3 2026	YTD Q3 2025	Change
Adjusted EBIT of Industrial Activities	324	429	(24)%
Adjusted EBIT Margin of Industrial Activities	2.9%	3.9%	(100) bps
Adjusted Net income	387	457	(15)%
Adjusted diluted EPS $	0.30	0.36	(0.06)
Free cash flow used in Industrial Activities	(449)	(304)	(145)

	Agriculture
(All amounts in millions of dollars)	YTD Q3 2026	YTD Q3 2025	Change	Change at c.c.(2)
Net sales	8,780	8,792	-%	(2)%
Adjusted EBIT	370	539	(31)%
Adjusted EBIT margin(1)	4.2%	6.1%	(190) bps

	Construction
(All amounts in millions of dollars)	YTD Q3 2026	YTD Q3 2025	Change	Change at c.c.(2)
Net sales	2,217	2,103	+5%	+4%
Adjusted EBIT	52	63	(17)%
Adjusted EBIT margin(1)	2.3%	3.0%	(70) bps

	Financial Services
(All amounts in millions of dollars)	YTD Q3 2026	YTD Q3 2025	Change	Change at c.c.(2)
Total Revenues	1,967	2,020	(3)%	(6)%
Net income	68	224	(70)%
Adjusted Net income(1)	224	223	-%

Huawei Chronicles 30 Years of Wireless Innovation in a Documentary for the First Time

Tue, 10 Nov 2026 06:25:00 +0700

Source: Huawei

Key Message:

*Huawei has officially launched Signals of Change, a four-part documentary series that, for the first time, offers global audiences a comprehensive look at the company's major technological innovations in wireless communications over more than three decades.

*The documentary highlights Huawei's landmark innovations, including Distributed Base Stations, SingleRAN, Massive MIMO, Polar Code, MetaAAU, and "0 Bit 0 Watt".

*Through real-world scenarios such as high-speed rail connectivity, network coverage in extreme environments, and connectivity at major sporting events, the documentary hears from global telecom operators, industry analysts, and other stakeholders to showcase the global impact and value of Huawei's wireless innovations.

SHENZHEN, CHINA - Media OutReach Newswire - 6 November 2026 - Huawei today officially launched Signals of Change, a new documentary series that, for the first time, charts the company's major technological innovations in wireless communications over more than three decades. Produced by Huawei in collaboration with CNN International's brand studio Create, the series will be broadcast worldwide.

Huawei's wireless business began in 1994, but it was in the early 2000s that it began to break into international markets. Huawei developed its distributed base station innovation, marking a historic breakthrough into the European wireless communications market. From its early struggles to gain a foothold to its determined progress in recent years, Huawei has consistently sought to overcome obstacles through innovation and meet challenges with resilience, continuing to advance amid technological transformation and intense market competition.

Through real-world scenarios such as high-speed rail connectivity, network coverage in extreme environments, and connectivity at major sporting events, the documentary hears from representatives of leading global telecom operators, industry analysts, Huawei executives, and R&D experts. It revisits landmark innovations including Distributed Base Stations, SingleRAN, Massive MIMO, and "0 Bit 0 Watt", tracing Huawei's journey from an industry newcomer to a leader in technological innovation and industry development.

From Distributed Base Stations to SingleRAN: Driving Mobile Network Deployment Through Architectural Innovation

On a high-speed train traveling at nearly 350 kilometers per hour, a surgeon can download hundreds of CT scan images over a mobile network to provide timely remote medical consultations. At altitudes exceeding 6,000 meters in the Mount Everest region, scientific researchers can stay connected with colleagues thousands of miles away through real-time video links, enabling remote scientific collaboration. From high-speed railways to the roof of the world, the first two episodes of the documentary explore how mobile communications technology continues to overcome the limitations of speed and geography. To trace the architectural innovations behind these advances, the story takes us back more than two decades to the early days of 3G network deployment in Europe.

In the early 2000s, European telecom operators faced significant challenges in deploying 3G networks, including difficulties in acquiring sites, lengthy deployment cycles, and high costs. In 2004, Huawei engineers visited customer sites to gain firsthand insights into these challenges and pioneered a distributed base station architecture comprising a compact Baseband Unit (BBU) and Remote Radio Units (RRUs). This innovation enabled operators to deploy network equipment more flexibly while significantly reducing network construction costs. Huawei's distributed base stations were first deployed in the Netherlands in 2005, followed by large-scale commercial deployment in Spain in 2006. Over time, the distributed base station became a mainstream architecture for mobile network deployment worldwide.

As the coexistence of 2G, 3G, and other mobile networks created growing challenges of duplicated infrastructure, Huawei made further breakthroughs in key technologies, including GSM multi-carrier digital predistortion (DPD), and introduced its SingleRAN solution. By integrating multiple radio access technologies on a unified hardware platform, SingleRAN enabled operators to deploy different network standards together and smoothly evolve their networks across successive generations of mobile technology. In 2008, a German telecom operator became the first in Germany to deploy Huawei's multi-mode base station solution, marking the beginning of SingleRAN's commercial adoption in Europe. Since then, SingleRAN has been widely deployed around the world, driving the evolution of mobile networks toward multi-band, multi-mode integration while helping operators significantly reduce network deployment and operating costs.

From Massive MIMO to Polar Code Implementation: Turning Cutting-Edge Research into Real-World Applications

At the Nanjing Olympic Sports Center, 62,356 football fans gathered for the Su Super League final. Spectators shared highlights in real time on their smartphones, with photos, videos, and live-streaming data flowing rapidly across mobile networks. This high-density connectivity, featured in Episode 3, reflects the explosive growth in data demand in the mobile internet era. How to accommodate ever-increasing data traffic using limited spectrum resources has long been a major technical challenge for the mobile communications industry.

Huawei has continuously invested in Massive MIMO (Multiple-Input Multiple-Output) research, leveraging innovations such as large-scale antenna arrays to bring this cutting-edge technology from theoretical research to commercial deployment. In 2015, Huawei worked with an operator partner in Shanghai to successfully validate Massive MIMO in a commercial network environment. Today, Massive MIMO has become one of the key technologies underpinning 5G networks, laying a solid technological foundation for the world's transition to the 5G era.

Meanwhile, Huawei has continued to explore innovations in fundamental research. In 2008, Turkish scientist Erdal Arıkan introduced the theory of Polar Codes, opening up a new direction in channel coding technology. Building on this theoretical breakthrough, Huawei invested in Polar Code encoding and decoding algorithms and system-level validation. In 2016, through the efforts of Huawei and global industry partners, Polar Codes were selected by 3GPP as the coding scheme for 5G enhanced Mobile Broadband (eMBB) control channels, becoming an important part of the international 5G standard.

From MetaAAU to "0 Bit 0 Watt": Delivering Superior Network Performance with Ultra-Low Energy Consumption

Episode 4 shifts the focus to the green transformation of wireless networks. As demand for mobile connectivity continues to grow, reducing network energy consumption while meeting rising performance requirements has become a shared challenge for telecom operators worldwide.

In 2021, Huawei launched MetaAAU, its next-generation Massive MIMO product. Through innovations including ultra-large-scale antenna arrays, MetaAAU pushed beyond the performance limitations of conventional antenna architectures. By enhancing network coverage while reducing energy consumption by approximately 30%, MetaAAU has helped operators achieve both higher network performance and greater energy efficiency.

In 2021, Huawei and its European customers jointly introduced the "0 Bit 0 Watt" concept. Through coordinated innovations in hardware, materials, software, and intelligent network management, the solution enables wireless equipment to enter ultra-deep sleep modes during periods of low traffic and wake up on demand, reducing network energy consumption while maintaining user experience. In 2024, the solution received the GSMA GLOMO Award for "Best Mobile Technology Breakthrough", offering a new technological pathway for telecom operators worldwide to advance their green transformation.

A Journey of Relentless Innovation: Driven by Customer Needs and Scientific Advancement

From transforming base station architectures to enabling multi-standard network integration, from breakthroughs in key algorithms to contributing to global standards, and from continuous product evolution to achieving ultra-low energy consumption, Huawei's journey of wireless innovation over more than three decades has been guided by a consistent commitment: addressing customer needs to drive innovation and scientific exploration to push technological boundaries. These efforts have continuously advanced global network capabilities, creating new possibilities for the digital economy and a more connected society.

Looking ahead, Huawei will remain committed to its dual-driver approach to innovation, continue to increase investment in fundamental research and development, respect and protect intellectual property rights, and embrace openness and mutually beneficial collaboration. Working alongside partners worldwide, Huawei aims to advance mobile communications technology and contribute to a thriving global industry ecosystem.

Where to Watch:

Watch the documentary via media's YouTube link, or follow Huawei's official social media channels to discover the full story of the Signals of Change documentary series.

Q1: Why has Huawei chosen to release this documentary series on wireless innovation now?

A: Huawei aims to offer global audiences a comprehensive look at its major technological innovations over more than three decades. Through authentic stories, technological breakthroughs, and industry achievements, the documentary showcases Huawei's capabilities in original innovation and raises awareness of its contributions.

The global mobile communications industry is entering a pivotal stage in the development of next-generation networks. Through this documentary, Huawei hopes to highlight its long-standing commitment to innovation driven by both customer needs and scientific advancement, sustained investment in fundamental research, and collaborative innovation with global partners. Huawei will continue to carry these principles forward as it explores new technologies and contributes to the development of next-generation mobile networks.

Q2: How do the technological innovations featured in the documentary relate to people's everyday lives?

A: The mobile connectivity we take for granted today is built on decades of continuous technological innovation. From distributed base stations that made mobile network deployment more flexible and cost-effective, to SingleRAN, which enabled the integration and smooth evolution of different generations of mobile networks, and Massive MIMO, which dramatically increased network capacity, each breakthrough has expanded the possibilities of mobile communications. More recently, innovations such as MetaAAU and "0 Bit 0 Watt" have helped operators achieve both improved network performance and greater energy efficiency.

Whether staying connected on a high-speed train, sharing memorable moments in a stadium filled with tens of thousands of fans, or accessing reliable mobile services in remote areas, these everyday experiences depend on the combined capabilities of multiple generations of communications technology. The documentary aims to show audiences that the seamless connectivity we expect is the result of generations of technological progress-and that these innovations will continue to shape our digital lives in the years ahead.

The issuer is solely responsible for the content of this announcement.

Hashtags: #Huawei

Hologen and Sysmex establish Saibogen, a joint venture using AI to turn routine blood test data into clinical intelligence

Tue, 10 Nov 2026 06:12:00 +0700

The joint venture will apply generative AI to the detailed hematology data in routine blood counts, aiming to give researchers and clinicians a richer view of each patient, with no new instruments, reagents or samples

LONDON and KOBE, Japan, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Hologen (HQ: London, UK; CEO: Roland Tegeder), a frontier AI company, and Sysmex Corporation (HQ: Kobe, Japan; President: Iwane Matsui), a global leader in hematology, today announced Saibogen, a blood intelligence company formed as a joint venture between the two companies.

Saibogen will apply Hologen's Large Medicine Models, generative AI models that learn the biology underpinning real-world healthcare data, to proprietary data generated by Sysmex hematology analyzers. The approach aims to unlock new insights from routine blood testing data, with no new instruments, reagents or samples, and to create new clinical value for healthcare professionals and researchers.

Hematology testing is one of the most widely performed laboratory investigations worldwide and often serves as a starting point for medical care. Sysmex hematology analyzers alone run approximately 3 billion? of these tests each year, producing a precise, standardized set of values that clinicians around the world rely on. With Saibogen, Sysmex and Hologen are launching a mission to uncover the hidden biological signals in data that Sysmex hematology analyzers already generate.

Saibogen's ambition is to change what a hematology analyzer is for: from an instrument that reports a standard panel of parameters to a platform that delivers rich and dynamic biological insight without compromising accessibility. Saibogen will deliver these insights to its partners in healthcare and clinical research from tests they already perform, helping them bring more predictive, preventive and personalized care to patients worldwide.

Saibogen brings together the strengths of Sysmex and Hologen, creating a company with a unique opportunity to improve healthcare. Sysmex brings extensive expertise in hematology, proprietary data, product development capabilities and a global business platform. Hologen contributes more than a decade of fundamental research by its scientific co-founders into applying AI to the most challenging data in medicine. Building on early collaborative research by Hologen and Sysmex, and on the companies' access to routine blood data at scale, Saibogen will deliver its blood intelligence products as software exclusively through Sysmex's hematology analyzers. Saibogen's first offerings will be for research use only.

"What if a routine blood test were also one of the most informative in medicine?" said Leila Luheshi, CEO of Saibogen. "Every routine blood count measures tens of thousands of cells with remarkable precision, and much of that information goes unused. We are building the AI to read it in full, so researchers, laboratories and clinicians can learn far more from a test that is already part of everyday care."

"Every day, laboratories around the world rely on Sysmex hematology analyzers to support clinical decision-making," said Iwane Matsui, president of Sysmex Corporation. "Over decades, Sysmex has built not only deep expertise in hematology, but also a global business platform through which high-quality, standardized hematology data is generated every day. Through Saibogen, we aim to combine this foundation with Hologen's AI technologies to unlock new value from routine blood testing data and support researchers, healthcare professionals, and ultimately patients."

"Blood is one of the richest sources of biological information we have," said Roland Tegeder, CEO of Hologen. "Our Large Medicine Models are built to learn that biology from real-world data. Working with Sysmex, Saibogen can apply them at global scale and turn the most routine measurement in medicine into blood intelligence that researchers and clinicians can act on."

? Based on Sysmex research. The number of CBC tests, calculated based on reagent consumption, is monitored as one of the key performance indicators (KPIs) for Sysmex's sustainability targets. See Sysmex Sustainability: Materiality.

About Saibogen

Saibogen is a blood intelligence company working toward a world where a routine blood test is one of the most informative in medicine. A joint venture of Hologen and Sysmex Corporation, Saibogen builds on Hologen's Large Medicine Models to learn from the data that Sysmex hematology analyzers capture in every test and will deliver its products as software through Sysmex's hematology analyzers, with no new instruments, reagents or samples. Saibogen is based in Singapore. Learn more at Saibogen.com.

About Hologen

Hologen is a frontier AI company developing Large Medicine Models. These multimodal models are trained on large-scale, real-world clinical data from healthcare partners and learn the underlying biology of each patient. This allows Hologen to make more accurate diagnoses, understand how disease progresses, predict response to treatment and model patient outcomes.

The company applies these models across diagnostics, drug development and health systems, and is advancing its own portfolio of therapeutic programmes. Hologen works with leading healthcare, pharmaceutical and technology companies to bring better diagnosis and effective medicines to patients sooner.

For more information, visit www.hologen.ai.

About Sysmex

Sysmex Corporation, headquartered in Kobe, Japan, is a global leader in in vitro diagnostics. Since its foundation in 1968, Sysmex has focused on diagnostics as the core of its business, and today, it supports the health of people in over 190 countries and regions worldwide.

Sysmex continues to innovate in diagnostics, and to collaboratively create unique values in the areas of personalized medicine and novel treatments, under its long-term vision of "Together for a better healthcare journey."* Through its unique technology, solutions, and co-creation with various partners, Sysmex delivers new value and addresses the universal desire of people to live longer and healthier lives.

For more information about Sysmex, please visit www.sysmex.co.jp/en/.

*"Healthcare journey" is a trademark of Sysmex Corporation, registered in Japan.

When Seconds Matter: Indonesia's Anesthesia Teams Take On a Live Crisis Simulation Competition

Mon, 09 Nov 2026 16:28:00 +0700

Source: Comen Medical

BALIKPAPAN, INDONESIA - Media OutReach Newswire - 9 November 2026 - On November 6, 2026, CO-Anesthesia: Share with the World - Indonesia Anesthesia Crisis Management Simulation Competition 2026 concluded at Platinum Hotel & Convention Hall, Balikpapan, as part of PIB XIX PERDATIN 2026 KALTIM.

Supported by Comen Medical and held in collaboration with PERDATIN, the event marked the first national final in this year's "CO-Anesthesia : Share with the World" Simulation Competition series.

Real-World Experience Meets the Demands of Crisis Response

In anesthesia practice, a crisis can develop within moments. An airway emergency, severe bleeding, or sudden cardiovascular instability demands more than individual knowledge: teams must assess the situation, communicate clearly, coordinate roles, and act decisively while keeping patient safety at the centre.

Against this clinical backdrop, nine finalist teams representing major teaching hospitals, referral centres, and regional anesthesia services across Indonesia brought experience from diverse perioperative and critical-care settings to the stage. From case presentation to live simulation and debriefing, the teams demonstrated how they would identify priorities, interpret evolving clinical information, and coordinate their response when a crisis disrupts routine practice. The finalists were:

*ARISE-UI - RS Cipto Mangunkusumo

*ThinkTank Team - RSUP Dr. M. Djamil Padang

*Balinesthesia 1 - RSUP Prof Dr. IGNG Ngoerah Denpasar 1

*Code Blue Studio - RS Prof dr Chairuddin Panusunan Lubis

*Anestesi Unpad - RSUP Dr. Hasan Sadikin Bandung

*GAMA-CITO - RSUP Dr. Sardjito

*Aremanest UB - RSUD Saiful Anwar Malang

*Balinesthesia 2 - RSUP Prof Dr. IGNG Ngoerah Denpasar 2

*IAC Anestesi Unsoed - RSUD Margono Soekarjo

From Expert Assessment to Shared Professional Learning

The live final was guided by a distinguished panel of anesthesia and intensive care experts from Indonesia and the Philippines. Their combined clinical, educational, and professional experience brought depth to the evaluation, which considered broad dimensions including case design, clinical management, technical and non-technical performance, patient safety, and the educational value of debriefing.

Following the final assessment, IAC Anestesi Unsoed from RSUD Margono Soekarjo emerged as the national champion and will advance to the planned 2027 Asia Grand Final in Malaysia. The value of the final extended beyond the ranking. Through observation, expert feedback, and professional discussion, the live format enabled participants and observers to compare approaches to the same underlying pressures, examine the role of leadership and teamwork, and exchange practical perspectives on crisis response. This is the central purpose of simulation-based competition: to turn demanding scenarios into a shared learning experience that can inform future practice.

Building the Next Stage of Collaboration

During the event, Comen Medical and PERDATIN signed a Memorandum of Understanding on strategic cooperation in medical education, simulation-based training, and academic exchange. The MOU provides a framework for the two parties to explore future collaboration in areas such as simulation-based learning programmes, hands-on workshops, continuing education activities, and professional exchange, with specific initiatives to be developed through separate agreements and work plans.

More than a competition, CO-Anesthesia connects real clinical experience with structured simulation and cross-border exchange. Following the Indonesia final, competitions in India, and the Philippines will continue the series, extending its focus on team readiness and professional learning across more anesthesia communities.

More information is available at:

https://en.comen.com/events/co-anesthesia-indonesia-2026

About Comen Medical

Comen Medical, founded in 2002, is a research-driven enterprise committed to independent innovation. For over two decades, the company has been dedicated to the fields of life support, medical imaging, and informatization, while continuously expanding into in-vitro diagnostics (IVD) and large-scale surgery. For more information, please visit https://en.comen.com/.

The issuer is solely responsible for the content of this announcement.

Hashtags: #Comenmedical

CNH Announces Agreement to Form a Joint Venture by Selling a 70% Interest in its Construction Equipment Business to Kobelco Construction Machinery

Mon, 09 Nov 2026 16:23:00 +0700

CNH Announces Agreement to Form a Joint Venture by Selling a 70% Interest in its Construction Equipment Business to Kobelco Construction Machinery

*Transforms CNH into a leading, pure-play agriculture equipment, technology, and services company with a strengthened financial profile

*Creates joint venture that operates as a global manufacturer of construction equipment, with an enhanced ability to invest and innovate to better serve customers

*Transaction values CNH's Construction Equipment business at an enterprise value of $1 billion; CNH to receive cash and 30% ownership in the joint venture; transaction expected to be accretive to CNH margins

Basildon, UK - November 9, 2026 - CNH Industrial N.V. (NYSE: CNH) today announced a definitive agreement with Kobelco Construction Machinery Co., Ltd., a wholly owned subsidiary of Kobe Steel, Ltd. (collectively, "Kobelco"), to establish a joint venture that will operate CNH's Construction Equipment business ("CE JV"). Kobelco will be the majority owner of the CE JV. The transaction continues CNH's transformation into a leading, pure-play agriculture equipment, technology, and services company with a strengthened financial profile and gives it enhanced capacity to invest in products, precision technology, and its global dealer network.

"This transaction significantly advances CNH's portfolio simplification and sharpens our focus on agriculture in line with our Path to 2030," said Suzanne Heywood, Chair of the CNH Board of Directors. "As the largest pure-play agriculture machinery OEM, CNH will be better positioned than ever to invest with conviction and create value for farmers, dealers, and shareholders at every point in the cycle."

"We are confident that this is the right next step for CNH, our dealers, customers, and colleagues," said Gerrit Marx, Chief Executive Officer of CNH. "As the agriculture industry moves toward recovery, this transaction strengthens CNH's ability to invest in the products and technologies that matter most to farmers. At the same time, by creating a stronger construction equipment player, both CNH and CE JV dealers, along with their customers, will benefit from a suite of high-quality, cost-competitive construction machines that incorporate leading technology."

Marx continued, "We undertook a comprehensive process to evaluate how best to position our Construction Equipment business, and it was clear that Kobelco is the right long-term steward, and that our joint venture approach will ensure a smooth transition for the business and our team members who support it. The CE JV will be a leader with the scale, focus, and agility to invest, accelerate innovation, and better serve global construction customers."

At closing, CNH will continue to provide full-line agriculture applications through the Case IH, New Holland, STEYR, and CNH Tech brands, including the Raven precision technology platform. CNH agriculture dealers will have continued access to a suite of competitive construction equipment machines supplied by the CE JV. CNH Capital will remain part of CNH. The transaction is expected to be accretive to CNH's margins.

This transaction marks the next step in CNH's multi-year strategic transformation journey to sharpen its technology-led focus on agriculture, which began with the acquisition of Raven Industries in 2021 and the separation of the on-highway commercial vehicles business through the spin-off of Iveco Group in 2022. This transaction now enables CNH to deploy its resources entirely to the products and technologies that matter most to farmers.

Creating a Stronger Construction Equipment Player in the CE JV

This transaction brings together CNH's Construction Equipment business' strong brands, broad product portfolio, global sales and service network, and strong customer base with Kobelco's technological capabilities and product strengths in hydraulic excavators and cranes, and construction DX (digital transformation) solutions including K-DIVE remote operation technology. The complementary geographic footprints of CNH's Construction Equipment business and Kobelco will establish a stronger global platform for continued growth.

Humayun Chishti, President of CNH's Construction segment, said, "This is a tremendous opportunity for our team, our dealers, and our customers. We are adapting to changing dynamics in the construction sector and a greater pace of innovation. Kobelco is the ideal partner - a global excavator and crane specialist with leading technology, including K-DIVE remote operation technology. Together as the CE JV, we will deliver a complementary portfolio built for long-term growth, and benefit from a stronger platform to do what we do best - build exceptional machines and deliver outstanding support to the people who rely on them every day." Chishti is expected to continue leading the business as CEO following closing.

The CE JV will offer a comprehensive portfolio spanning a broad range of earthmoving, lifting, and compaction applications across the heavy and compact segments - including excavators, loaders, graders and dozers, compact track loaders, skid steer loaders, and tractor loader backhoes - currently sold under the CASE Construction, Eurocomach, and New Holland Construction brands. The CE JV's products will continue to be supported by the high-quality service and support available worldwide to customers today, through the same channels. CNH Capital will continue to support the CE JV's customers and dealers with a full range of retail financing, leases, rental programs, and insurance products.

Transaction Details

The transaction values CNH's Construction Equipment business at an enterprise value of $1 billion. CNH expects to receive $700 million in cash consideration for 70% of the business, subject to adjustments for net debt, working capital, and other customary items. CNH expects to use these net cash proceeds to reduce debt and strengthen its balance sheet. CNH will retain a 30% equity ownership position in the CE JV. Each party will be subject to a three-year lock-up period. To provide continuity and facilitate a smooth business transition, CNH will continue to remain a strategic partner to the CE JV.

The joint venture will be established through the creation of two companies that will jointly operate as the CE JV.

The transaction is expected to close by the end of 2027, subject to regulatory approvals and other customary closing conditions.

Kobelco issued a separate press release in connection with this announcement. CNH will also report its 2026 third quarter earnings results in a separate announcement later today, available at https://investors.cnh.com.

Advisors

BofA Securities and Goldman Sachs & Co. LLC are acting as financial advisors to CNH. Pillsbury Winthrop Shaw Pittman LLP is acting as legal advisor to CNH. Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. is acting as financial advisor to Kobelco Construction Machinery, and White & Case LLP is acting as legal advisor to Kobelco Construction Machinery.

Conference Call and Webcast

CNH will host a conference call and live webcast today at 9:00 am ET to discuss its 2026 third quarter earnings results and the transaction. The webcast, along with related presentation materials, will be available on the Investor Relations section of CNH's website at investors.cnh.com. A recording of the conference call will be available later at investors.cnh.com.

About CNH

CNH (NYSE: CNH) serves and advances the people who feed and build a growing world.

We are an iron-and-tech company, engineering intelligence, automation, and precision into the machines that move the global economy. Our equipment operates in more than 160 geographies, supported by a global team of more than 34,000 people, including engineers, technologists, and industry experts.

Our brands ? Case IH, New Holland, STEYR, CNH Tech (including the Raven precision technology platform), and CNH Capital ? together generated $18.1B in revenue in 2025.

Building on a legacy of innovation dating back to 1842, CNH has achieved multiple milestones including the first mass-produced tractor, the first twin-rotor combine, and the first factory-integrated precision farming system. Today, we are engineering autonomous and predictive machines that will shape the future of food and infrastructure.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements other than statements of historical fact contained in this press release are forward-looking statements, including statements relating to the proposed transaction; the expected timing of the closing of the transaction; the satisfaction of the conditions to closing; the expected cash consideration to CNH and the expected use of the net cash proceeds; the expected effect of the transaction on CNH's margins and financial profile; CNH's strategy and portfolio transformation, including its Path to 2030 and Iron + Tech strategy; the expected benefits of the transaction to CNH, CE JV and their respective dealers, customers and suppliers; the expected leadership of CE JV; the anticipated commercial relationships between CNH and CE JV; and the expected future performance of CE JV and CNH's retained interest in CE JV.

Forward-looking statements are based on current expectations and assumptions and are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond CNH's control. Factors that could cause actual results to differ materially from current expectations include, among other things: risks related to the effect of the announcement or pendency of the transaction on CNH's relationships with dealers, customers, suppliers and others with whom CNH does business, its ability to retain and hire key personnel and its operating results and business generally; the possible diversion of management's time and attention from ongoing business operations and opportunities; the ability of the parties to consummate the transaction on a timely basis, in the expected timeframe or at all; the satisfaction or waiver of the conditions precedent to consummation of the transaction, including the ability to obtain regulatory approvals, on the terms expected, at all or in a timely manner; the occurrence of any event, change or other circumstance that could give rise to a right to terminate the transaction; the ability to successfully run the future joint venture; the costs, fees, expenses and charges related to the transaction; the effect of contractual adjustments, including for net debt and working capital, to the consideration to be received by CNH; CNH's ability to use the net cash proceeds as currently anticipated, including to reduce debt; CNH's ability to realize the anticipated benefits of the transaction, including to its operating results and financial profile, and to successfully execute its agriculture-focused strategy; risks related to the internal reorganization and separation of the Construction Equipment business; the expected future performance of CE JV and the value of CNH's retained interest, including the effects of dilution and of transfer restrictions during the lock-up period; the length of time CNH remains a stockholder of CE JV and the level of future ownership; the effect of early release from the lock-up; CNH's limited ability to control CE JV as a minority owner; the ability of CE JV to supply construction equipment to CNH's agriculture dealers and the terms thereof; the effect of any legal proceedings related to the transaction; general economic conditions and conditions in the agriculture and construction markets in which CNH operates and CE JV will operate; and other risks described in CNH's Annual Report on Form 10-K for the year ended December 31, 2025 and its subsequent filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release. CNH undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.

Nexawork AI Launches Custom Software for SMEs From RM19,900.00

Mon, 09 Nov 2026 16:14:00 +0700

Source: Nexawork AI

An Asia digital transformation programme for founders and SMEs, starting in Malaysia, with a full refund if the delivery date is missed

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 9 November 2026 - Fully customised business software and AI solutions, built by engineers and backed by a full refund if the agreed delivery date is missed. Starting in Malaysia and rolling out across Asia, made possible by more than 100 partners.

Nexawork AI is an Asia focused technology company building the AI Business Operating System. It was co-founded by Allen Tan Chee Hoe, its Chief Executive Officer, and Sky Wee, its Chief Business Development Officer.

Today Allen Tan Chee Hoe announced the launch of Nexawork AI's Asia digital transformation programme, which helps founders, project owners and small and medium enterprises (SMEs) build their first digital product. It offers custom software development, including AI solutions and AI agents, starting with a Starter Pack at RM19,900.00, with a full refund of the development fee if Nexawork AI misses the delivery date in the contract.

The programme starts in Malaysia, its first market in Southeast Asia, before extending across Asia. Applications are open now at nexawork.ai. Its pricing is made possible by more than 100 partners, who share the work and bring businesses to the programme.

Why Asia's SMEs hold back on AI and digital transformation

Asia runs on small businesses. Across 26 economies tracked by the Asian Development Bank (ADB), micro, small and medium enterprises make up 99.8% of all enterprises, employ 67.6% of the workforce and produce 38.7% of national output. Yet many still run on paper and spreadsheets, SME digitalisation lags, and AI is widening the gap. In South Korea, a 2024 Korea Federation of SMEs survey of 300 SMEs found only 5.3% using AI, and the obstacle cited most was the lack of AI services built for their needs.

Cost and risk add to the hesitation. In Malaysia, 2026 industry estimates put even a basic first version of mobile software at RM30,000 to RM60,000, and most SME projects at RM60,000 or more. For a first time founder, that is a large bet on one vendor. Owners are avoiding risk, not technology.

"Transformation fails on the first invoice, not on the technology," said Allen Tan Chee Hoe, Co-Founder and Chief Executive Officer of Nexawork AI. "We are not trying to reprice the market. We want to give many SMEs the confidence to take their first step into digitisation, together with more than 100 partners, so a founder anywhere in Asia can build a first digital product without betting the year on it. And we are not here to replace anyone's workforce. Our AI brings productivity to business owners and their teams, so that adoption actually happens."

A full refund if the delivery date is missed

If Nexawork AI misses the delivery date in the contract, the business receives a full refund of the development fee. The clock starts when the business provides complete information and access, and the scope is fixed in writing before work begins.

Custom software development and AI solutions built around the business

Every system is shaped around the individual business. Professional engineers write, review and test every build, and the owner needs no technical knowledge. Projects can include a native mobile platform for ordering, payment through the business's own provider, delivery tracking and referrals, an admin console, connections to existing software, and AI built for the business, from AI solutions on its own data to AI agents that answer enquiries or follow up on orders.

RM19,900.00 is the Starter Pack, the entry point to the programme: a focused first system built around one core workflow, such as taking orders or bookings, with an admin console for the owner. Builds with more features, AI, payments or integrations are scoped and priced above the Starter Pack.

Why the programme price is possible: more than 100 partners

The programme is designed to grow the market, not to undercut it. The price is not set to compete with the market: most SMEs would not commission development at RM100,000 or more, so the programme reaches businesses that would otherwise not digitise at all, rather than taking work from established developers. The Starter Pack can start at RM19,900.00 because more than 100 partners share the work and bring businesses to the programme, so less of each project's price goes on sales and marketing.

Nexawork AI's team shapes each founder's first product before any code is written. Lavie System Solutions brings almost two decades of development experience, so proven building blocks are not reinvented for every project. Healing Mind Group, led by Lee Hong Rui, a trainer accredited by HRD Corp, Malaysia's Human Resource Development Corporation, joins as Business Process and SME Transformation Partner to map workflows and prepare teams. Dova Space looks after the people side of change, Eco Bee Biotech and Eco Bee Shop introduce the programme to their network, and Jayv Chang Yoon Voon, marketing partner for Southeast Asia, reaches businesses through partner and community channels.

How the programme works

Each custom software development project starts with a written scope, after which the price and the delivery date go into the contract. The build runs in about twelve sprints over about three months. Every project includes three months of free maintenance; hosting, domain and infrastructure are paid by the business to its own providers, from about US$100 a month. Every system is built to connect directly to the Nexawork AI platform, which is expected to launch by the second quarter of 2027.

The founders behind Nexawork AI

Allen Tan Chee Hoe is a serial founder and product architect with 15 years of experience in technology and product development. According to internal operating records, he previously built a startup to more than 4 million users and 60,000 business owners, and his teams have supported more than 180 projects globally for companies that together raised more than US$200 million. Sky Wee, who leads global business development and partnerships, is a Singapore based serial entrepreneur and venture investor.

The Nexawork AI Partner App

Nexawork AI will also launch the Nexawork AI Partner App, expected in the first quarter of 2027, so referral partners can refer businesses to the platform and handle enquiries and introductions in one place. Partners can register their interest at nexawork.ai.

Larger digital transformation projects

Alongside the programme, Nexawork AI is helping established companies digitise through larger projects, each scoped and priced on its own and separate from the RM19,900.00 Starter Pack. They include Vorahome, a home services platform founded by Alan Foong, Vincent Wong and Ivan Hiew Chin Woon; and Big Ben Dining Group, a food, entertainment and technology dining concept founded by Bengemen Tan Boon Yong.

How to apply

To claim the programme, a business needs an official Programme Code from the Nexawork AI sales team. Founders, project owners and businesses can apply at nexawork.ai or approach any Nexawork AI Sales Manager across Southeast Asia. A salesperson will contact them to confirm the fit and issue the code, which opens the scoping session; the sales team verifies each business through its code and uses it to track every approved project. The programme is open while it lasts, until Nexawork AI announces its close, and codes, like places, are limited each month.

About Nexawork AI

Nexawork AI is building the AI Business Operating System for solo entrepreneurs, small teams and established businesses in Asia: one platform to run your work and your business. Money and legal commitments always wait for a human. The platform is in beta with design partners and is expected to launch by the second quarter of 2027. Nexawork AI was co-founded by Allen Tan Chee Hoe, its Chief Executive Officer, and Sky Wee, its Chief Business Development Officer. Work Less. Win More. AI Does the Rest. nexawork.ai

About Eco Bee Biotech and Eco Bee Shop

Eco Bee Biotech and Eco Bee Shop is a Malaysian bee biotechnology, conservation and wellness enterprise founded by Cathie Tan in 2002. It develops Kelulut (stingless bee) honey, propolis and other wellness products, and in 2026 was recognised by ASIA Records and ASEAN Records for its alcohol free halal Kelulut propolis extract. Bee conservation is at the heart of its mission, including its planned Eco Bee Nature Exchange, guided by its philosophy: Save Bees, Empowering People, Pure Quality. beeshop.com.my

About Lavie System Solutions

Lavie System Solutions, led by Lai Yu Long, is a Johor based development company founded in 2008 that builds custom software, enterprise and point of sale systems and online stores. lvss.com.my

About Healing Mind Group

Healing Mind Group is a training provider led by Lee Hong Rui, who brings experience in finance and corporate management, a background in process transformation and trainer accreditation with HRD Corp. It helps SMEs map their business workflows, identify operational gaps and prepare their teams to adopt systems that improve productivity.

About Dova Space

Dova Space, led by Debbie Hew Sio Yee and Hew Khai Rin, is a holistic health and wellness centre offering personalised, data driven care. It brings Traditional Chinese Medicine, modern medical expertise, natural healing and advanced medical devices under one roof, with a strong focus on sleep health: sleep care consultations, sleep quality and autonomic nervous system assessments, home use medical devices and long term sleep management programmes. Better Sleep. Better Health. Better Living. dova.space

The issuer is solely responsible for the content of this announcement.

Hashtags: #NexaworkAI #WorkLessWinMore #DigitalTransformation #CustomSoftware #AIforBusiness #AIAgents #SMEMalaysia #SMEDigitalisation #SoftwareDevelopment

https://nexawork.ai/

https://www.linkedin.com/company/nexaworkai

https://web.facebook.com/nexaworkai

Asia Pacific Irish Business Forum 2026 Secures Significant Sponsorship and Support from Leading International Organisations

Mon, 09 Nov 2026 16:06:00 +0700

Ten sponsors and 12 supporting organisations back a two-day Hong Kong forum on 19 and 20 November connecting Irish and Asia-based businesses

HONG KONG SAR - Media OutReach Newswire - 9 November 2026 - The Irish Chamber of Commerce of Hong Kong today announced the sponsors and supporting organisations behind the Asia Pacific Irish Business Forum 2026, taking place on 19 and 20 November at the Island Shangri-La, Hong Kong. Ireland's Neale Richmond, Minister of State at the Department of Foreign Affairs with special responsibility for International Development and Diaspora, is among the confirmed speakers.

The forum will bring together senior business leaders, investors and policymakers from Asia Pacific and Ireland for two days of keynotes, sector panels and structured networking.

Sponsors are Air Mount Technic, Airwallex, BMW, Crown Worldwide Group, InvestHK, the Irish Whiskey Association, Osome, Precious Metals Asia and Savantas Policy Institute.

Supporting organisations include Irish Chamber of Commerce China; Meetings and Exhibitions Hong Kong (MEHK), a division of the Hong Kong Tourism Board; the Government of Ireland's Department of Foreign Affairs and Trade (Global Irish); and Bord Bia ? the Irish Food Board, together with Enterprise Ireland, Chambers Ireland and Asia County Board GAA. Irish chambers of commerce from across the region, including Indonesia, Macao, Singapore, Thailand and Japan, also support the forum.

Padraig Seif, President of the Irish Chamber of Commerce of Hong Kong, said:

"The strength of support behind the forum shows how much appetite there is for closer commercial ties between Ireland, Hong Kong and the wider region. Ireland and Hong Kong share a stable common-law legal system, making each a natural gateway for the other. For Hong Kong and Asian businesses, Ireland is the best platform for expanding into Europe as it is an English-speaking EU member with proximity to the UK. Irish companies, in turn, can use Hong Kong as a springboard into Asia.

The programme covers eight sectors: Agri-Foods, Aviation, Education, Finance, Pharma, Tech/AI, Tourism, and Regional Connectivity and Collaboration. More than 30 speakers are confirmed.

Attendees can meet Irish business and agency representatives and network with Asia-based Irish Chamber delegates. There is also an evening reception with the Gaelic Athletic Association and an exclusive whiskey tasting with the Irish Whiskey Association, featuring Ahascragh, Clonakilty and Lough Ree distilleries.

Registration is open through the Irish Chamber of Commerce of Hong Kong events page. The Full Pass costs HK$2,000 (approximately US$260) and covers the conference and networking reception. The tasting requires separate registration due to limited seating.

About the Asia Pacific Irish Business Forum 2026

Hosted by the Irish Chamber of Commerce of Hong Kong, the Asia Pacific Irish Business Forum 2026 fosters closer business ties between Hong Kong, Ireland and markets across Asia. It strengthens collaboration among regional Irish Chambers of Commerce, connects Ireland-based chambers and businesses with opportunities across the Asia Pacific region, and facilitates introductions and business matching between Irish and local interests.

About the Irish Chamber of Commerce of Hong Kong

The Irish Chamber of Commerce of Hong Kong champions Irish businesses and professionals, offering a trusted hub for connection, collaboration and knowledge-sharing within the city's international business community. As we work to strengthen commercial and cultural links between Ireland and Hong Kong, we also support new and existing members to uncover opportunities, build meaningful partnerships and navigate Hong Kong's dynamic business landscape.

For enquiries, contact us at admin@irishchamber.hk or connect with us on LinkedIn.

The issuer is solely responsible for the content of this announcement.

Hashtags: #theIrishChamberofCommerceofHongKong